From: Subject: ATSDR - Cancer Fact Sheet Date: Wed, 27 Jun 2007 12:20:49 -0600 MIME-Version: 1.0 Content-Type: multipart/related; type="text/html"; boundary="----=_NextPart_000_0084_01C7B8B5.99126760" X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.3138 This is a multi-part message in MIME format. ------=_NextPart_000_0084_01C7B8B5.99126760 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable Content-Location: http://www.atsdr.cdc.gov/COM/cancer-fs.html ATSDR - Cancer Fact = Sheet
Skip directly to: content = | left = navigation=20 | search
  1. Home = >=20
  2. Cancer Fact Sheet

Cancer Fact Sheet

    Overview

    Cancer is not a single disease. It is a group of more than 200 = different=20 diseases. Cancer can be generally described as an uncontrolled growth = and=20 spread of abnormal cells in the body. Cells are basic units of life. = All=20 organisms are composed of one or more cells. Normally, cells divide to = produce=20 more cells only when the body needs them.

    Sometimes cells keep dividing and thus creating more cells even = when they=20 are not needed. When this happens, a mass of tissue forms. This mass = of extra=20 tissue is called a tumor. Tumors are found in all kinds of tissue, and = can be=20 benign or malignant.

    Tumors

    Benign

    Benign tumors are not cancer. They usually can be removed and, in = most=20 cases, they do not come back. Most important, cells from benign tumors = do not=20 spread to other parts of the body. Cells from benign tumors stay = together and=20 often they are surrounded by a containing membrane. Benign tumors are = not=20 usually a threat to life.

    Examples of Benign Tumors =
    • Papilloma - A projecting mass on the skin (for example, a = wart)

    • Adenoma - A tumor that grows in and around the glands

    • Lipoma - A tumor in fatty tissue

    • Osteoma - A tumor originating in the bones

    • Myoma - A tumor of muscle tissue

    • Angioma - A tumor usually composed of small blood or lymph = vessels (for=20 example, a birthmark)

    • Nevus - A small skin tumor of one variety of tissues (for = example, a=20 mole).

    Malignant

    Malignant tumors are cancer. Cancer cells can invade and damage = tissues and=20 organs near the tumor. Cancer cells also can break away from a = malignant tumor=20 and enter the lymphatic system or the bloodstream, which is how cancer = can=20 spread to other parts of the body. The characteristic feature of = cancer is the=20 cell's ability to grow rapidly, uncontrollably, and independently from = the=20 tissue where it started. The spread of cancer to other sites or organs = in the=20 body through the blood stream or lymphatic system is called = metastasis.

    Malignant tumors generally can be classified in two categories.

    • Carcinomas. These cancers originate in the epithelium. The = epithelium is=20 the lining cells of an organ. Carcinomas are the most common type of = cancer.=20 Common sites of carcinomas are the skin, mouth, lung, breast, = stomach, colon=20 and uterus.=20
    • Sarcomas. Sarcomas are cancers of connective and supportive = tissue (soft=20 tissues) of all kinds. Sarcomas can be found anywhere in the body, = and they=20 often form secondary growths in the lungs.

    Characteristics of Benign and Malignant Tumors

    Characteristic Benign Malignant
    Differentiation Tumor cells resemble the original mature cells Tumor cells might not resemble the original mature cells =
    Growth Rate Slow; might stop or regress Rapid, autonomous; usually does not stop or regress
    Type of Growth Expand and displace Invade, destroy, and replace
    Metastasis No Yes
    Health Effect Usually does not cause death

    May cause death if not diagnosed and treated =

    Some Causes of Cancer
    Different types of cancer = have=20 different causes and are likely to depend on many factors. Some = cancers are=20 more common than others, and chances for survival vary among different = types.=20 Most cancers do not have known causes from a chemical, environmental, = genetic,=20 immunologic, or viral origin. Cancers also can arise spontaneously = from causes=20 that are thus far unexplained.

    The causes of cancer are very complex, involving both the cell and = factors=20 in the environment. Much progress has been made in identifying = possible causes=20 of cancer, including:

    Chemicals and other substances. Being exposed to=20 substances such as certain chemicals, metals, or pesticides can = increase the=20 risk of cancer. Any chemical that is known to cause cancer is called a = carcinogen. Asbestos, nickel, cadmium, uranium, radon, vinyl chloride, = benzidene, and benzene are examples of well-known carcinogens. These = may act=20 alone or along with another carcinogen, such as cigarette smoke, to = increase=20 the risk of cancer. For example, inhaling asbestos fibers increases = the risk=20 of lung diseases, including cancer, and the cancer risk is especially = high for=20 asbestos workers who smoke.

    Tobacco. The most common carcinogens in our = society are=20 those present in cigarette smoke. Tobacco smoke is known to contain at = least=20 60 carcinogens and 6 developmental toxicants. In addition to being = responsible=20 for 80 to 90 percent of lung cancers, cigarette smoking is also = associated=20 with cancers of the mouth, pharynx, larynx, esophagus, pancreas, = kidney, and=20 bladder.
    Avoiding tobacco products is one way to decrease a = person's risk=20 of cancer.

    Ionizing radiation. Certain types of radiation, = such as=20 x-rays, rays from radioactive substances, and ultraviolet rays from = exposure=20 to the sun, can produce damage to the DNA of cells, which might lead = to=20 cancer.

    Heredity. Certain types of cancer occur more = frequently in=20 some families than in others, indicating some inherited predisposition = to the=20 development of cancer. Even in these cases, however, environment plays = a part=20 in the development of cancer.

    How Cancer Develops
    Cancer can develop in = people of all=20 ages, but it is more common in people over 60 years old. One of every = three=20 people will develop cancer at some point in their lives. Because = people are=20 living longer, the risk of developing cancer is increasing.

    The development of cancer is a long process that usually starts = with=20 genetic changes in the cells, and continues in the growth of these = cells over=20 time. The time from genetic change to development of cancer is called = the=20 latency period. The latency period can be as long as 30 years or more. = This=20 means that some cancers diagnosed today may be due to genetic changes = that=20 occurred in the cells a long time ago.

    Theoretically, the body develops cancer cells continuously, but the = immune=20 system recognizes them as foreign cells and destroys them. The body's = ability=20 to protect itself from cancer can be impaired by some drugs and viral=20 infections.

    Symptoms of Cancer
    Everyone should be familiar = with=20 certain signs that may indicate early cancer. It is important to = report them=20 immediately, before the condition spreads. It is unfortunate that = early stages=20 of cancer are typically painless; because they are painless, diagnosis = and=20 treatment are often delayed.

    Early symptoms can include

    • unaccountable weight loss
    • unusual bleeding or discharge
    • persistent indigestion
    • the presence of white patches inside the mouth or white spots on = the=20 tongue

    Detection of Cancer
    Early detection and prompt = treatment are directly responsible for increased survival = rates.
    Tools for=20 cancer detection include

    • Self-exams
    • Biopsy (the removal of living tissue for the purpose of = microscopic=20 examination of cells)
    • Ultrasound (the use of reflected high-frequency sound waves to=20 differentiate various kinds of tissue)
    • Computed tomography (CT) (the use of x-rays to produce a = cross-sectional=20 picture of body parts)
    • Magnetic resonance imaging (MRI) (the use of magnetic fields and = radio=20 waves to show changes in soft tissues without the use of x-rays).=20
    Health Promotion Tips
    • Reduce or avoid exposure to known or suspected carcinogens or=20 cancer-promoting agents, including cigarettes and sun exposure.
    • Eat a balanced diet that includes vegetables, fresh fruit, whole = grains,=20 and adequate amounts of fiber.
    • Reduce the amount of fat and preservatives in the diet, = including smoked=20 and salt-cured meats.
    • Participate in regular exercise.
    • Obtain adequate, consistent periods of rest (at least 6 to 8 = hours per=20 night).
    • Eliminate or reduce stress and enhance the ability to = effectively cope=20 with stress.
    • Go to annual health check-ups.
    • Enjoy consistent periods of relaxation and leisure.
    • Learn to practice self-examination (breast and testicular).
    • Seek immediate medical care if cancer is suspected.

    Risk Factors for Cancer
    Because cancer is not a = single=20 disease, it does not have a single cause. Many causes or risk factors = can=20 contribute to a person's chance of getting cancer. Risk factors are = different=20 with each type of cancer. It is important to remember that 1 in 3 = people will=20 develop a cancer during their lifetime.

    Risk factors can include such things as age, race, sex, genetic = factors,=20 diet, and exposure to chemicals, radiation, and tobacco.

    Genetics play a large role for many cancers, such as breast and = colon=20 cancer. This means that a family's health history can be a risk factor = for=20 some types of cancers.

    Lifestyle Factors
    Personal choices we make = about the=20 way we live our lives can increase our chance of developing cancer. = These=20 choices are called lifestyle factors, and they include smoking, heavy=20 drinking, and eating foods that have excess calories, high fat, and = low fiber.=20 Other factors that increase risk are related to sexual contact and = sunlight=20 exposure.

    Tobacco
    Thirty percent of all cancers are = attributed=20 to smoking or chewing tobacco. Cigarette smoking is also associated = with=20 cancers of the mouth, pharynx, larynx, esophagus, pancreas, kidney, = and=20 bladder.

    Diet
    Researchers found that different types of = food=20 you eat affect your risk of developing cancer. Approximately 30% of = cancers=20 are related to diet.

    Infectious Agents
    Some viruses have the = ability to=20 transform cells into cancer. Examples include (a) human papilloma = virus (HPV)=20 and cervical cancer, and (b) Epstein-Barr virus and lymphoma.

    Occupational Exposure
    Occupational exposure = includes=20 high-risk occupations such as uranium miners, asbestos factory = workers,=20 certain chemical plant workers, and workers in nuclear power = plants.

    Reproductive Factors
    The reproductive factors = category=20 refers mostly to women's risk factors. For example, the risk of breast = cancer=20 goes up if a woman does not have children before the age of 30. = Sexually=20 transmitted diseases also increase the risk of cervical cancer.

    Sedentary Lifestyle
    Not moving around much = during the=20 day may increase the risk of cancer. The body's own defenses work = better when=20 you exercise and maintain an ideal weight. Moderate exercise such as = walking=20 or climbing a flight of stairs can help.

    Alcohol/Drugs
    Alcohol contributes to the risk = of=20 developing cancer. People who drink too much or abuse drugs may not = eat well=20 or take care of themselves, which will increase their overall risk of=20 cancer.

    Pollution
    Although people think environmental=20 pollution is a major of cancer, in fact few cancers have been found to = be=20 caused by pollution, but research is still ongoing. The cause of many = cancers=20 is not known. Other factors that interact to increase the risk of = cancer are=20 age, hormonal balance, response to stress, and status of the immune=20 system.

    Risk and Protective Factors in the Development of Cancer=20

    Protective Factors Risk Factors
    Type of
    Cancer     		Vegetables Fruits Physical
    Activity     		Alcohol Obesity Tobacco
    Use    		 Environmental
    Exposure
    Lung GL SL ML MR   HR SR
    Colon/Rectum GL   GL SR MR MR  
    Breast
    		 SL SL ML SR SR    
    Prostate
    		 ML           MR
    Stomach
    		 GL GL         MR
    Oral/Pharynx
    		 GL GL   MR   HR MR
    Kidney ML       SR MR  
    Ovary
    		 ML ML          
    Pancreas
    		 SL SL       HR  
    Liver
    		 ML     HR     MR
    Cervix
    		 ML ML       HR  
    Bladder
    		 SL SL       HR SR
    Esophagus GL GL   HR   HR MR
    Larynx
    		 SL SL   HR   HR MR
    Thyroid
    		ML ML         SR
    Uterus
    		 ML ML     HR    
    Gallbladder
    		         MR    
    Nasopharynx           SR MR

    GL =3D Greatly lowers your risk
    SL =3D Somewhat lowers your risk =
    ML =3D=20 Might lower your risk
    SR =3D Somewhat raises your risk
    MR =3D = Might raise=20 your risk
    HR =3D Highly raises your risk

    Adapted from: Westcott S. A Journey Into Cancer's Causes. Anchorage = (AK):=20 Alaska Native Health Board; 1999. p. 11.

    Cancer and Children

    It can be especially difficult to understand and accept when a = child=20 develops cancer. The most common cancers in children are leukemia, = brain=20 tumors, and lymphomas. Nearly 1 in 450 children will be diagnosed with = cancer=20 before the age of 15.

    Many pediatric cancers occur very early in life and many parents = want to=20 know why. The cause of most childhood cancers is not known, although = some of=20 these cancers are the result of genetic predisposition (cancer runs in = the=20 family). Radiation exposure also contributes to certain types of = childhood=20 cancers. Other factors that have been implicated in childhood cancers = include=20 infectious diseases, prenatal conditions, environmental pollutants,=20 electromagnetic fields, and use of medications.

    Unlike most cancers of adults, childhood cancers are not = significantly=20 related to lifestyle risk factors such as tobacco or alcohol use, poor = diet,=20 or not enough physical activity. Many organ systems in children are = undergoing=20 rapid growth and development in the first years of life. These systems = are=20 especially vulnerable to injury during these periods of = development.

    The types of cancer that occur in children vary greatly from those = seen in=20 adults.

    Most Common Cancers in Children and Adults

    Children Adults
    Leukemias: acute lymphocytic = (lymphoblastic) Lung
    Brain and Other nervous system tumor: = neuroblastoma Breast (carcinoma)
    Lymph-node cancers (lymphomas) Colorectal
    Bone (osteosarcoma) Prostate
    Soft-tissue sarcomas: rhabdomyosarcoma Skin (melanoma)
    Kidney: Wilms tumor  
    Eye: retinoblastoma  
    Adrenal gland (adrenocortical carcinoma)  

    This information on children and cancer was compiled from = "Childhood=20 Cancer-General Statement", published by the American Cancer Society.=20

    Acute lymphocytic leukemia (ALL) is the most = common=20 childhood malignancy. ALL accounts for almost one-third of all = childhood=20 cancers.

    Brain and spinal cord cancers are the second most = common=20 cancers in children. Most brain cancers of children involve the = cerebellum or=20 brain stem. Adults are more likely to develop cancers in different = parts of=20 the brain -- usually the cerebral hemispheres. Spinal cord tumors are = less=20 common than brain tumors in both children and adults. =

    Bone=20 cancer is uncommon. The incidence of primary bone cancer = (cancer=20 starting in bones) is highest in children and adolescents. Cancer that = spreads=20 to the bones is more common than primary bone cancer in all age = groups.=20 Osteosarcoma is the most common type of primary bone cancer in = children and=20 young adults. Ewing sarcoma is a less common primary bone cancer that = occurs=20 mostly in children and adolescents.

    Detecting Cancer in Children
    Cancers in = children are=20 often difficult to recognize. Parents should take their children to = regular=20 medical checkups and should be alert to any unusual signs or symptoms = that=20 persist. It is important to report unusual signs or symptoms to a = health care=20 provider.

    Unusual signs or symptoms include=20
    • unusual mass or swelling
    • unexplained paleness
    • loss of energy
    • sudden tendency to bruise
    • persistent, localized pain or limping
    • prolonged, unexplained fever or illness
    • frequent headaches, often with vomiting
    • sudden eye or vision changes
    • excessive, rapid weight loss.

    What About Chemicals in the Environment?

    "All substances are poisons: there is none which is not a poison. = The right=20 dose differentiates a poison and a remedy."

    Environmental pollutants are only one of the many connections = between=20 cancer and our lives. Not all contaminants are deadly or even cause = disease.=20

    The amount of a contaminant a person is exposed to
    plus the = length of=20 time that person is exposed
    plus how many times that person is = exposed=20
    plus how the person was exposed
    equals whether a person will=20 experience negative health effects from an exposure.

    Exposures to some chemicals in the environment, at home, and at = work may=20 contribute to an individual's risk of developing cancer. Toxic = substances such=20 as benzene, asbestos, vinyl chloride, and arsenic can increase the = risk of=20 cancer in those exposed to them. The International Agency for Research = on=20 Cancer (IARC) classified these substances as known human carcinogens = because=20 studies showed a link in humans between exposure to these substances = and=20 cancer.
    Some chemicals have been shown to cause cancer in animals, = but=20 there is not enough evidence to show that these chemicals also cause = cancer in=20 humans. These chemicals are classified by IARC as possibly or probably = carcinogenic to humans. Chloroform, DDT, formaldehyde, and = polychlorinated=20 biphenyls are examples of such chemicals.

    Most of what we know about chemicals and cancer in humans comes = from=20 scientists' observation of workers. The most significant exposures to=20 cancer-causing chemicals have occurred in workplaces where large = amounts of=20 toxic chemicals have been used regularly.

    The amount of toxic chemicals found in food, air, and drinking = water are=20 typically much lower than those in the work environment. Therefore, = cancer=20 risk from environmental exposures is thought to be lower compared to = the risk=20 in occupational settings. In fact, the cancer risk from environmental=20 exposures is often difficult to measure.

    Environmental Toxicants

    Environmental toxicants are classified by the National Toxicology = Program=20 as (a) known human carcinogens and (b) reasonably anticipated to be=20 (suspected) human carcinogens to differentiate the level of evidence = available=20 to support the carcinogenicity of a probable toxicant. Carcinogens = include a=20 wide diversity of synthetic and naturally occurring substances, = including=20 hormones, immunosuppressants, organic and inorganic chemicals, and = cytotoxins.=20

    It is difficult to study populations living near a hazardous waste = site and=20 determine if their cancers are associated with exposures. A major = difficulty=20 for those studying these populations is not knowing the exact level of = individual exposure to a carcinogenic agent. Waste sites often contain = more=20 than one chemical, which makes it difficult to associate health = outcomes to a=20 single exposure. Often other variables must be accounted for before = making any=20 associations of the disease outcome to a given exposure from the site. =

    Because of the long latency period of cancer development and the = type of=20 behavioral risk factors associated with cancers (such as tobacco use, = alcohol=20 consumption, and diet), it is difficult to collect information about=20 environmental exposures that occurred years ago.

    A List of Known and Suspected Human Carcinogenic Agents by=20 Organ

    = =
    Human Carcinogenic = Agent
    Organ Known Suspected
    LungArsenic
    Asbestos
    Benzo(a)pyrene
    bis(Chloromethyl)ether
    Ch= romium
    Nickel=20 subsulfide
    Zinc chromate
    Tobacco smoking
    Mustard=20 gas
    Uranium    		Acrylonitrile
    Beryllium
    Cadmium
    1,2-Dibromo-3-chloropropane<= BR>Polyclic=20 aromatic hydrocarbons (PAHs)
    Kidney Coke oven emissions
    Zinc chromate    		 Tetrachloroethylene
    Bladder Benzidine Tetrachloroethylene=20
    Cyclophosphamide
    4-Aminodiphenyl
    Tobacco=20 smoking
    Chloraphazine     		Tetrachloroethylene
    Stomach Zinc chromate Ethylene oxide
    Skin Arsenic
    Benzo(a)pyrene
    Overexposure to the sun     		PAHs
    Tetrachloroethylene
    Liver Vinyl chloride
    Aflatoxin
    Alcoholic drinks     		 
    Mouth, pharynx,
    larynx, esophagus    		 Alcoholic drinks
    Tobacco smoking
    Tobacco chewing (mouth=20 only)
    Mustard gas (larynx)     		 
    Prostate Cadmium  

    Source: Lybarger JA, Spengler RF, DeRosa CT, editors. Priority = health=20 conditions: an integrated strategy to evaluate the relationship = between=20 illness and exposure to hazardous substances. Atlanta: Agency for = Toxic=20 Substances and Disease Registry; 1993. p. 61.


    For more information about Cancer:

    Contact your Health Care Provider
    Your local American Cancer = Society=20 Chapter
    or visit the following sites on the Internet:
    http://cancernet.nci.nih.gov/<= IMG=20 height=3D11 alt=3D"Exiting the ATSDR Web Site."=20 src=3D"http://www.atsdr.cdc.gov/img/exit.gif" width=3D30>
    http://www.yourcancerrisk= .harvard.edu/
    http://www.cdc.gov/cancer3D"Exiting
    http://www.acor.org/
    http://www.pbs.org/wgbh/nova= /cancer

    References

    Mosby's Patient Teaching Guide, Editor, Harrison, Alison (1995), = Mosby Year=20 Book, Inc.

    Medical/Surgical Nursing, 5th Edition, (2000), Lewis, Sharon; = Heitkemper,=20 Margaret; Dirksen, Shannon; Mosby.

    A Journey Into Cancer's Causes, Wescott, Siobhan, (2001),, Alaska = Native=20 Health Board

    Professional Guide to Diseases, (1995), 5th Edition, Springhouse=20 Corporation

    The Human Body in Health and Disease, 7th Edition,(2000) Memmler, = R.; Wood,=20 D.; Lippincott Williams & Wilkins

    Memmler's Structure and Function of the Human Body, 7th Edition = (2000);=20 Cohen, B.; Wood; D; Lippincott, Williams & Wilkins

    What You Need to know about Cancer of the Cervix, (1994), National=20 Institutes of Health, National Cancer Institute

    Priority Health Conditions: An Integrated strategy to Evaluate the=20 Relationship Between Illness and Exposure to Hazardous Substances; = (1993);=20 Lybarger, J.; Spengler, R.; DeRosa, C.; Agency for Toxic Substances = and=20 Disease Registry

    Cancer Warrior, NOVA On-Line, (2001); = www.pbs.org/wgbh/nova/cancer

    Cancer Source Book for Nurses, 7th Edition; (1997); American Cancer = Society

    Cancer Facts and Figures 2001; (2001); American Cancer Society

    Childhood Cancers; (2001); Pediatric Oncology Resource Center,=20 www.acor.org.diseases/ped-onc/diseases/diseases.html

    NCI Fact Sheet: National Cancer Institute Research on Causes of = Cancers in=20 Children; (1999);
    www.oncolink.upenn.edu/pdq_html

    Cancer Information Service; www.fhcrc.org/cipr/pnwcis

    For more information,
    contact ATSDR's toll-free information = line:=20
    (888) 42-ATSDR. . .(888) 422-8737



This page updated August 30, 2002




Agency for Toxic = Substances and=20 Disease Registry, 1825 Century Blvd, Atlanta, GA 30345
CDC Contact = Center:=20 800-CDC-INFO =95 888-232-6348 (TTY) 
3D"USA.gov:
3DDHHS=20=20
Department of Health
and Human = Services=20
------=_NextPart_000_0084_01C7B8B5.99126760 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.atsdr.cdc.gov/images/logo.gif R0lGODlhHQI3AMQAAAQsYcjI5sXF1KenzomJrvDw9o2NzWVlvEhIr0FLdygooWlsla2usODg8eLh 6VVVijA8cIqPlXh4xHl+nlVofri425mbse7r5/r28tbW3r+/vxERlwA5dv///wAAkBoaYSH5BAAA AAAALAAAAAAdAjcAAAX/4CeOpNidaKqubOu+cByXdG3feK7vfO//wKBwSCwaj8ikcsnzOJ9QZ4dD rVqv2Kx2y+16uZ2oeEwum8/otHrNbrvf8Lh8Tq/b7/i8Wjf9+v+AgV4dTIWGh4iJiouMjY6PO2h9 gpSVllphepqbnJ2en6ChoqOkaHyXqKmUhJCtrq+wsbKztEaSqri5YKW8vb6/wMHCw3WnusfIrLXL zM3Oz9DRH7fI1biZxKUKCBvZ3t/g4eJ7OZPW55XKOgTsBAvSPQ8FHQ8jEAQQIxMTPA/0Jf7qHelA gMS9fCL2KbonwEKCIBMswJtIUQg1dBgDYZOUooECPBIQ2FEg4SOaAQGi/yDoINJJhQpqVopEIMGJ TDsdaj656RJmpw0FClQoYOCNgZTjkiotVi6j0z/qyhX8sMCBAyUEkQTcIUAAwH8iuvb7R4DV1oFT RZz9IBZRWREJEFacS5fJRT8A8gJ4emzjmZw7WXpQMKBDAJEKKhhoQLQb4Q4FDgyucKCChAodGsBU 3KCDAQMFGrREEKDDgI+VDXSooOBA6QBFoZA2/XGoUNk5EegO4HP2aQ8bQHv2IHPx6gMrQYtWWdqj h9SrTUpgrFqnzdy7YVZ28tnDZ8yWGeucvrrb9+FQDuTstrP078oIGlx2khhBd+LuP05v/LyB/KUA AmjMHxRccIEGfOkSFf8OWY1AEAQFFDRBBxD4k8ECZUl0D1UU+uMAAROUJUBBHTiwQGEVPJDBVQt0 8NAAV2W4QAEDPFDYAPyM4E+NGWDwAQFWpfWBPyp41eKLV/0IAYQLBDSBAAQ94I8AKiY5QpMfWJDB jx1YMOMAHNaImZBEpuDVW2x5BWWIJdpIoZJsSbRmWTmOAKVpIhz5AYxcjphAB/wQUECaQ5p2YpYO 5JPBABAQpFBdkNZy1xcZnJBogtesAZgTG+QkgaefIieYdw3QJ8Gnuo3qwaaA3fSpBwPIJ4FqJGXy EnGqOoESp4DdiltI2cEqK62DHTBdSIK9iqtIyso2axjK3noUr9bhCiz/aTBFu5lPrQq2AU23+rop FAqoNoCwp9L6KXsBnNtAUbfu+oRQp1bg0WolBajvOAN6AUCLJ2CQAKaqLHhDg3tSWFY7BEgJlqB7 FmBBWQ4L9EGDWW31VgUftnMPK2KtFZZXJhTUlo5gEcoxwxBMOACQDZNllswlrEhAYVyO/EEFJF9M ZspioSlWWxnTk0ABIw5NMsIlWEDIyh6j+cGEZT2kNAlIMzykBQ4MGunXsUzaRaUoTLAXwZf4ZQa+ 5EmmQAE12YfrABu8fS7cy/K0qgHddMtsGK5Kpu2y7DmhnkjE+hpYSx7cGjisMHWK7N8bfJvsRgoI ppoHg4fK+bjLPnHr/6cKvL2tFHGzpCxvjXNbLWkIuHbu4816EBRSt6onmWSLKRAcariatO/wxPTL BQARqMDA2Win00MKFbyT5zx4WnhCBvk4LUBhFY9QGCFF14NmWScUJDTJDnTQswhOQ5bjyWoBTTL5 WbWYgQAZxFzP0VHSTEIGSMNMzgi1s+sxbS1tSV8BHKCmpRUkIBBi4NV8RoIZnaABD+FS+QbIPkDp LEsoqAdmIPOAowGwAmBLoSvEpgUIXEAFGWhe2kZiEpmUjlzCGwMCcmgGbpjhWzwEDuPg4EP6BJE+ Rexh4cpwwzYk8QzfYsMOxfBENXyrcFHcyRGJx8VeGE8LAGBAwFCAAf8IWEIvmDJYEUSmwja68Y1w NAQLsZAADHSAAWJEAQWqEBcI6CUvSwpkFQCQAAoYMgFnA0Agl5SARsYFjVZQZB8d6UfmWUFtdEjM FrvIyU568pO8+CIWAKCBEkGAAimIwF4A0CMMYOACK3LABVzZAQ3sJQEasKMuNTAw5F1AlkFxpSsd oAEKWBIAAjCQgewIS1ViQY1xjKY0p0lNRcxxkKgEFCHteAJbcoCUAtAAA8jWgQwwQAMCWF4CXsgA RFKgUr2kHwMMSYEI3KmWfqwC2RxAgQXk8Y6W5AAmQUnQghr0oNkQpRUgUClvQiB9JyiAGfPyzX/p 8Y9hLBFFCelNDkz/6ATGpEJeIsBNAVjhTjHMyz9DWgVoVvOlMI2pTHFwzW8mT2AiLaUer2DREyCy Ci6sJfMo+s2PuuiY7euAMzmgU5N+M5tdsuRAEUrVqlr1qnZQKBWCurwqJFWbkQSYiwb5pw5c4KdY ECtLgQrRC5iRqSdwKgegagGpzvSueM1rTK+Z0UuJVKwAjaRRB8ZHbmZgrVVQ6yhXupem/rVsUrVi 5SZL2cpa9rKYzaxmN8vZznr2s6ANrWhHS9rSmva0qE2talfL2tEqFADZpMAH/lhHFGTgmION5D3v uNaedmCPPE3eCZzp2LzoFEFXcKlel8vc5kpjjqy8ngamO90epYCw/yId7FChGrCuUkGxPDVqXeGq PggkQIwY8O4lJdva9nr2AAYoyWlLp1n6khY57s1s7PLL3/6KFr/+DbBn9xtgUfo2BmYbZG7D+kIz vRW8gkXBeHX6yuvl85lC2FJdXpY+IQVhAfljmIipNAShfDhEXGOUDiAApfU1dwFdEUAF2GGB7Xl4 BCauBYy7MrGX3DgIQ1kEC9dZS3oamQL/jKqCUYDWQULAAg0+QVchvOThNrabeTxrQKkw1ShUdiUH EDBrA+A7IJ4WJWXuVAAmq4AMcIO09gWtAcJcOQW8q7N2XrOY91w5AwzAABV4c2cxI+gNVMYzaa5z ovmsWUJX7lMZWP+0aOPc3y9mtAA/HSpszRRJ4Y41CxxFQaJ8C9xIJjWkxw2q+rYs0A/nmCIwVgKY SKC+ClpsEQwtAYZ4AL83EkDDBHAxDihGA/tNhNgiKIxEJiK22o43C7U9gVut4Okmj1K4WjZqqa2w zyo0FXkoWOp600DZbRRG0oyWs55VW2g1lxvd/EVABizb7swGYN2fJUm6QxuABlRuJZ9VTb0NXZ59 y5klk10Jvvmrb9MaL7rTBiNEQWqFpGJXpMeslFsBoN0InyDBHLgTcsl2Vgz/4B1/+vEzeIaIWidB ej1o1LKB0OsdhEgadKKKldaRspq5qILNQHaYjADzG9ycCHfhuJX/t0DKVDLP4paMwFv1KVSPXtTJ EO1oyOP6VBRonctpSPSb/XNZ+wC63mYfQKH3W5kA0DnhKIFN6T7zmdbQ/bJtfpcBBI2AP9e9smpH AGU4a5jLHuDPA5CvoemuG8b3Gd/lurfaMasaN1e2XHOuHHwzX7l724c3b68bfGFT50/BZu//Rslp KMv2Crj9y3E3QJoxP4DQG0sx8K4zYw5gec8KnPKemexR2DyrwbP5M7Uv91ECzXoJDGDyCUf+wIWP 8M4XINEkoXuiZ/XnRB+gAGwePd/qZvrPvBm+hJE93WW/+fFvoF8QsKNft5Bkrf/z4vGvq15iu5fB znYvFJB1lkQ2/04VXR9nVz4QFwnxcyTwAEliQm0BYiLAJGohFF4CYgy4J9gzNbX2UCiUEB9IA4Li AFKCEAOgYUNiInmSPjD2agcjbIuiDw6QQWUxawtQAfnAUC5HFQVQD/IATe1zISSQAPczAgnAQHZC giJQg3byEAxVDxViGiVIFdhzNLM2JBa4ABiYQRqYDxNCMkeYQRmwbCCSbCo3AuQjFzBiSjYgdF/h FTrYMxomD0Y4gyIwhnChhCuiIx/4JFeiYRTYhoDyAE+iYv8jPVpiJzkyAEgjADd4Ak34AU8oiTtS gg8AJQTAMYPigfoQgtPwF0ClU+IGal9VRjl1dd/VTRNAAaWEAf8JBgBJRUzn1GAOMIoAAFExRAVQ ZYotFXbCR3c3UlkZ4H6MuA110wFvlwH+5htsFnwEJ2j2tRiTBWCXdW+UpR6JBhq+Uy4F11mFR1mx UlkBMG+VUxjc4H6VkwF6ljkSwGbTV2ffQ2aTZY3zuG70WI7IWDkdUGY7NFnOWDeR0Xl6xox15oyH w2Zldmd9to8b8Hp1844G4GbqEWkFSTeZ9Xtl940boI7/5m+aN1kKGRwMOYwLKXwWaWgFmYweeVnV MRvtdoLTmI/YWJAh4Tuq4Y/8mGb/SHAeQVnSqHmFNiDnZQEMMHVbwIoWQJS8lF0MQJT4Z0+zBEsO kUhIFgFKGU7/GmABFHBhg2SVSck85zRdC8A8ykUDdfIBAFQCCINsCyNiDiIkDeIAKFgCf5JBZ0kD 8LOHQ9gl8XNr5eBieEICEwJzKzIBcvFBOPMDEIAZPQM/JwM/jfKBQUIDCHODdrI+TBOXc4kyL8My EWMBh0kDjEiDgWkjOeCGFRSYBNQojtiApiFiSyIApHklUkgCbak1ggiFO2gCI8Iw4qMOOyg1k6mW HsY0H1CXCVECSUdUXYBRzIlRPCVJFRWdzglJ1Gmd0NmL5GZo3pePIOl+tNJ5HZBZO+mMGmlZ8iF6 mnWP7lZZ3ygTn3WeyfFl//g2C9eQelYa91V97HmP7Nmes1Ge/+hYZ4uBbwKqj/cpkgP3GIaBbupx khtQGAdQLpyFkZalGm93jwfQGQGpoJlFEvopfPMgGuIZcNUnoQm3kzFZZplzkjf5b6VxoJSlohuQ nq1RWVolQ+hQliQwcw7iiQ7ohAUAc1ASmm9Ja1NRAJtpm1tSdDUAP0hDmR/IRgyyPin3FXXyZKr5 QQKkA1JCAxkgEI7ZmIDpiRBQGHVinBYAJvCTmUm6pFzipCUgKJ6IhsZZKT56A6g5gQtEAr12iT9X FnKaJwLwMcXWNWHxJjuAbBHEmTZQAbOWiHZaAmfqQSVDnCLYpDRQUzpqDV0GBeRnWZixfadXaKox oP6Ijs5ojv+YlTk3up74xoiVpTv/Vn3euHCaUVnhWTd8g6GURY/q0Y6b1XeWRZH4+av2iG9g9pGP l6o+6ZHsKaOsOqvnOY0paniZcXmhkXvUF3p1VhqFRo/G2Hl8ox4JOpMvamYAeY40CnyCdqoFeX14 d3qKV5LMGhzrpqI06qre+n5N0akJwqPJZqQtIj0Qcpf2MA8wNwEZ5KZ8uoHJ9j9ekgMCsHMfUABn uT0o45dV+hVceLEwlxYCgGmXOQIAZDEE8LFL2AFF9wAzNwFeMzVKKqYxyxYoaCWmaQIz1ygFASFe 0bBwORUQArF7coeq+QDvkCIjYLFLu6XsUE72YAMoAhAA5KT/bZEAPeMORnuFSPsBSMgWhPAQR8cW Oaiw+qCydnprZgtCKLghXKOnyoCzV8iXSFoDYyinnAqwfYEGJIEiskegmEEUOxQARIEc/ZhwndEA vMENggcZpyEBlSIUHWkYnneN4Peh3zOMLAobsaMY8FgpiouqrBcr1/O3/5YBIeEadEYerBEfkCEB rnE93KAApaGOGdCv3+IejSesdQZA7UIaqOs7iqEYBZpmJ3gA6DdZQ/EZolK4qkFmjUsjJBG5FTC5 93YY3woZ90Zn3xcSqFd2McobqxcfBTCO9XZ41KN3ERkA9WpoMWp5moG87ke72uuQ8xBfExlmCCC4 sIu4mbG4/4bHiJlhuqpRTmFWwPf2t9/Hubrxb0ORGe14vMlbOcs7Z0ehvas3jZeLo/+qt04hsD5Q YzG2pcf5AEaqAwlgwjWQpz5QIRyrBCmMtopZQl76pTVAw5JYAxVipBWCtjZcwjpywjeQwjyMww34 wnT5w0aIxEdAxDTQwwZhMY10xDXgxEegxMcZYxVLsjpsxDrCxE1TA3nrwZmynZ2VfGzWALi7WtRo cG78xnAcx3Icb/I4WdORX208WTlKxrkAwou6pOyACAjrXIRcyEQwpJRpCIP8iWvDxxnxqW3gemIQ aJzQGlh1yZisFHpjEz6RB5Y8BnvsyKngxygsMSQwAIN6BI9VAaeG3MquvAMwwoWXyASrfANjLMqW AMltQBKWEV+bRAeC98uZPMzE3AuHF19zpgnBXAahjMu5/MrQHM3SvAS37MyCoMvFnM3avM1K0czW fM3THM7iPM6RAIrfvLfcnM7qvM7h4M3nDBXkHM/yTM7V/M5fgM3snM/6vM93wAcy8M8AHdAC/c/z XNAG7cohAAA7 ------=_NextPart_000_0084_01C7B8B5.99126760 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.atsdr.cdc.gov/images/logo_atsdr.gif R0lGODlhnwAWAMQAAO/59RCfcN/y7M/s4p/ZxTCsgyCmeY/SvFC5lq/fz2C/oHDGqb/l2UCzjH/M sv///wCZZgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAA AAAALAAAAACfABYAAAX/ICSOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcrkqNJ6NgMvp ahRSgYZhZYgms1JT9grpbl/U7LYbRjEe8EfD9WYVAPBBm9R4OFYOckh3cAgmfQwigX8vdX1/gXMp CgQPAg5ndpIqAg8Ibwsnj4CCR28KD4kliIp+MI6ukSusEA0DlqF3AAGVf3UQCp0ChiRwoSKjkX0D eAxXwakBgXBRlQ+3vqnXZAfNZA7eEAW3AmQjlb2Hqa1/vHAEYeDX6299cA6BbwIKKKwGAAAc3DKE 6paqOgiuOei0CcIBOMNqxZJj70AlARAACOjV4A0BA5USyMuWIMEDAg4f/yTotqvbgYW7TOZbBTEA gwR84sT5M+BSt0QFBdJ7ADJVg0ADHmIUtW6BJwgBVIow+SBMHZNS1Kx6Q3HikwcHRFRqgE7BFlmW RCTMJmIdgAEi2ODRqQAVgwXmygCE6GpEHwAMGHRyUEAnHANvtkRNBAuSoF/qEjk1FBVngE5PIVyt CtUKCXwpHSTrihLCWHHd4KJdiootBLdwy2gBiA/fHAMLBADIFAgBKjh7aC0qPKA2psRlhkp0PAcy zUT/Ag6EYJIAwC0IFXYiJqJTgoEGHgTE8xXsRQiDAUKQFXKk5gdtEz1ceX0+uF3obplLyODhu5yq LALBLQc8BJRCBr233GV6j8HHlCrjWMJPQRA4pccv0EREQoQAhFUhQLd8JVgqVxQgjCGyuAOYK7+s 41A464Vjk3iMjCAPAx01JJwr7pwUDx4mMQbfaM05yMSRSCap5JJMNunkk1BGKeWUVFZp5ZVYZnlk CAA7 ------=_NextPart_000_0084_01C7B8B5.99126760 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.atsdr.cdc.gov/images/ico_email.gif R0lGODlhDAAJAKIAAP///97e3ri4uAAAAP///wAAAAAAAAAAACH5BAEAAAQALAAAAAAMAAkAAAMd OLrM8PCtMKKklcYRgHqa13kVqIzkI0Rr2rJkIycAOw== ------=_NextPart_000_0084_01C7B8B5.99126760 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.atsdr.cdc.gov/images/ico_printversion.gif R0lGODlhDAALAJEAAP///wAAAP///wAAACH5BAEAAAIALAAAAAAMAAsAAAIZBIJpe9wcDjJxVYhT vA9LDU4OtHUWN4ZqAQA7 ------=_NextPart_000_0084_01C7B8B5.99126760 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.atsdr.cdc.gov/img/exit.gif R0lGODlhHgALALMAAP////zv8vnf5fXP2fK/zO+vv+yfsumPpeV/meJvjN9ff9k/ZdUvWdIfTM8P P8wAMyH5BAQUAP8ALAAAAAAeAAsAAARhEMhJq7046zyWX0OxBMFSGEn3LdJzEQ8hBwCjKAyAjMQR Ey1XBSYDAmAxHesoDDYlsM+k0ZDsoM+H9gmrIBwOhBJL2Q5/BIHAYTA4BFdm+SlReQwIhUSBQNWX LRuCg4SDEQA7 ------=_NextPart_000_0084_01C7B8B5.99126760 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://mtrics.cdc.gov/b/ss/cdcgov/1/G.5--NS/0?cl=Session R0lGODlhAgACAIAAAP///wAAACH5BAEAAAAALAAAAAACAAIAAAIChFEAOw== ------=_NextPart_000_0084_01C7B8B5.99126760 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.atsdr.cdc.gov/images/logo_USAgov.gif R0lGODlhkwA0APcAACQkWuTw5uXl5Wtlo6YELU1Qg76+yLk9YZuYtRwxarvCzHFpkNaTpch7jaYn RJ0KNI6LqJ+qvOvDzEJCdLxketm2vagNNeTHzCUic4mHjFxWlMzMzH18pq0BM0VChdmns8vI45mZ zDkveK6vzbEvU7hFYo2Hta8CN1lWhSgpYSUncry51GZmmeG3w6SmtcODlEdMg8NthjgzbX6Do9nO 0n2FmLURQ8TDyY6QuaIEN8u30ra1ul9cia0HObXA1ujK0t6TqMVMbb5BY8p8irsuUbgjTSIna9fW 5k9Mg7MAMpGPpTApdnVzpaanxiYcYcVefOeuvUdCeDMzZsPD3X5+smFZkoWEsFNPjFhSjqMMK87L 3PXv8e7R1by93KUYQyohenVzm6Ciuzc4bkA7e7RGX42OoNd0kcJAZqurwysoeb65zbS0ziopa5GM tNyfrtaVrdWGm0RBkPHm7lNig6KgxWBLkJucsbhVasdfesTF16wKMdDa5mdwmTMxcsVNcPDy74yE ree9v+nf59zGyVBbkfHb3mxpiOO7xrseS01LjLcRT5ecsK4sUrMCOb/G1od3pLQHPIaJstyotKwV Qs+Mns1rhE1JeyIhbZaat7O0yIF9r8vJ1ykpc7y+1Skja9uRqo2MtkZBgXl0nTw5crEHLDM2e7Ay V6+1xSgjc42Sr9F+nKmnvy4pa4F7p7BBYr06WlVRg9Sapltbjd+2vquoxb1AasjM13Jto9CFmt3G zLS02Ms9Y+jLz0NAeTkvdLi73igxbJ+f1enN4+32864hTFtals95lKQHMlxagaYIOM5YeMW93pqV va0ZSoSCp5aXtsV6mOO0yGZmmdDN6C8qYMxffmZkiz04e0M8gFJLj8m9wXNxloSBnLUjUMfK3dN6 lp6au8hRebolT87M1/XJ1vf397xTdMcwW9earK+eyk5Lkt2rtJ0OOrcXR7JEZ+r18ZKPrLQxWUQ9 c8VrjM262vfM1pmZmby9z64HPy8kcoyLrcW91l5cm3JxqqUAMKWlvSH5BAAHAP8ALAAAAACTADQA AAj/AAUIHEiwoMGDCBMqXMiwocOHECNKnEixosWLGDNq3Mixo8ePIEOKHEmy5McMJlOq7IhypcuX E1vCfCUOps2EMlO2aFEBjx4HL75RuklUYE6S9wS4snDCX5Kn5sgVJXq0oy00kfiN8eSphhwSPcLG gzK1aFWMK0DJusY1n68qkZr4EHTOH74cP8qa3fiPRR9OgGWBGmHQzwllNo7p3XsRzQBWqFBpaGMg 4TchAqG8WkzVIodRnkJxyNSwBWe9ZxsyYYPNijcBYcrgiJRKnz4Tbf4VXAWqd2+BI1hQw1IlUSJm Ame8PkiFyumKqRVuY3UrD8FpnZgABgzu3qaC4zpZ/wLArZMAMJ6YFNTghF8f8wf79HlOMfpBZr3a JDQROU2apAj9wkpynvBwEBNffAFgQWtwtQp9EtlXkCH6KQQBGxiyURlCK8giEDVpoIGQPEsocNAt S6iAAoQRSTiQEg3pExkqbCxoUCcGjuAJJ3Yg1AQGJhqUjwpEsgiRiwJo4VAqM6JiY0FTrFjGEkaI 8ORA11xJC41soKKPkQ4h+ZA+23Gy4UH3VCHAKpdsV8wzjhQUxkGWeMCGEUaEEhEDDXwgkASzFFQP Jd/gcsFAFZhWUAtkZSSmQ6AQSeQNCSmggQDesCGpCkt4wsoYLNCSUCjBZIjKDg7R4EVYHbQziBDJ vP8wEAU5nGDrCUIMIsAkJ8RC0AU59KDRozGWCR+aKwogi6RpbEokNqcYZIIVAlwzIwsN1WPDCZPE YEw3NhChhzECmQKJP0IY40cy/rQjAAXJBEFQJR3EMyxHMs54rEH3eIipGIBxVSYnl1CzRkHyCNRP PjsOyBAFPXiRi0CFuNIDAeQywI4/bgx0SDO4fnBCMgQx0gMu926Ub2RXDpQmQauhkkabZX4xBkEg wCJQJvn07MkzDE3SQSUErfOUrIyccEZBDYTFhdAMCPRDsBsRyxCZ27UskCNYGHSKMxoswQlXksYp EBN0DIQNK6wsEcVCuYTlJ0GJfSOAPx3AYVBYsVD/cIwfAsWQTBFVcwTPJTRbh9DLEEBw0CnbpOBf Go4LJIMVVsCDgzoplK3QIcl0oOhAZxzTwCxhBVqQP400sM7IAhGRDNEpazRCmSsk1MWKJuiJEAie EPmlAP8gAYpt+jjDLBgKQZFMEqoPdMDJs3SQzOgDhdWAAB100HEP/vBS+EZTcMUVAgnpYo0A4HjS RUK3EKybACwcTNAEGGIwX0LVi17QAR0wgwD4ZpAkHAMIAghHB4IAh2R0gyNWY0iG2LCNhDABHAK4 hycKkBB9FEkgpTAIAr5ghJmJaCBAcEctJCGQsMSgID1IArmIkQxlFCQWIzvUG/SgB1PMDoId0YSk /6gBgoPYQgYCuQdgmHcQUeTDQOxrxUFSgCFUJIIgHchCMrwgECH0wAYEeUIHejAEARije9EgCDF6 QIaBnOAYxzgBC8fHEUt0CRWwWM5A1iAC5AjAADNST0G88QUxDKQXujgIC76QIcVp4wSkIMUJDhWI HjxgEsYAwroQkQxVCCQex2hENYDQAHHoIRmHEsgdLJAELgLRIxxgQ7PYwALbaCIKvmjCQDokgH70 IRTgsI4W4MGGSzkiEhNIwRXgsSADQKAKnEgBYKoAATUIQBEEaMQDBfKGDhyjByd4QCx24Q9oDAQs BDglASYxN4EAIQeQqAZLQoIJFiSiZ1e4QggUMv8CE1ShCijQxLEMkIcVGBRK90ioQgGUCwpQQBgE aUElalEJXgTgDD0g10A+gYcSPEFvBpnFLMT3Spu0ARlVmBNIoiWAA+AhF1uI6TveEY8OkAsUJtIB PA7iDIOkwzaoukgEOXKPXhzhCNwQCKUKsgklIWQDAviOQM5kogh0TQClM8cfZroFN3SAHWkEBhIE MIAECGAPGwIBCOYw1YEgYxEAusc4BKK4I92kDfqwRUIFAAsOJCIPYzUeCyyRiSr0AgQiEIUvBJAP MMhAFJeyhDN4sIZRLAAMkcBGUj6RjGTEwwzf8EMjGoEZATghDpsoxaXq8AhZTMMSfNAACBLBBEH/ ymIb+mGCM7Bhi1CYIAoumAEdYMSQoW7EBJpwASjG0AV1DMM2A9gGM2ShWzogwzxXEMClPDTWFHRB MBo4ZheQQQ9CDGQIBoTjGykwkCVQYQ5MMBAMmCAL2/xBFqnQQCR6qixmvE8fV7BEF0wwCvX0YgB6 VIhxNyIDTWgCiaFwQTbu8Q9PCAAUtW1CFcxzKTV56FKssMUV6MCDToCiE8WYgiUK8gFjGAMdXCCI J2zhiUxowAC9AEUoFHAFsCkgEU3AlrK2cWINNAEbNl7DYkXhu+IW5R+kEYgdpAo0AZwiWvN7kG50 8yDHaWF+ldEN+mIkgC/pJhOdIM0pOlFEW7hgPSCrsM2bn9EJW5Q5KXTgr5PBxGeEELchC+6zoAMt aD4TutBGOjSiIaToRT+n0Y6OtKQnTelKW/rSmJ50QAAAOw== ------=_NextPart_000_0084_01C7B8B5.99126760 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.atsdr.cdc.gov/images/logo_dhhs.gif R0lGODlhOgA0ALMAAIqKiqurq+Dg4trZ25iYmMfEy3l5ebKysmFhYVJSUtjV2m5scdDO0NPT0ycn J+Xl5SH5BAAAAAAALAAAAAA6ADQAAAT/8MlJq7046827/2AojmRpnmiqrmzrlkURHAtgE0fQCO8m FIKAYREg5gwFRADQyzAGDsIjwOBNBIycjlBoVoYHRqcBCEibA4Cy+1EUCwzF64Bgjg4JgcO+CgTY JAMBDgYsBGVWJAcODgIEhSgDC5AlBowSlyoNJgiZjGcmg3wjjAkPCp8qfyR6ewKLDoAmDVyKjAEP lg4SoCV4uCIEjJuduw+ZJjibIQuXAgkOpqixKH6JHtCmx4RTjEAoBATXHAAOCA8Ft7mM4769HZcN jGLZ7ZWUHtHbmA4L9u4gFjG5BG2UChsgyh04VggZiwNIPnR6sKihthYQZVWQx6ijNnPHrc654LHs QrGOkKD9cMhCzYALhzDooghSAYBJC1EUACCuQkdGBsRQUFcK2k9jJYLkvLKQxk8DVgY5aGBGgNUC 9VJQ/fegga5oXRYgMPpuhQE/PgIY1fbMwVIXag+81LCSXTpgTZYYzHALqZcpajRawMqg318KdA5w mVshXd0yhyeUqcOlwMuX7B4Ue3s4zYAENmr4SxV5www/TJpFk1MaBNfWsGPLnk27tu3bfyMAADs= ------=_NextPart_000_0084_01C7B8B5.99126760 Content-Type: application/octet-stream Content-Transfer-Encoding: base64 Content-Location: http://www.atsdr.cdc.gov/images/btn_Go.gif R0lGODlhGwAUAOZ/ACcody9UfjBbijBZhSYndiwudjFilzBWgjJknTBflTNrqDNnoi4vbzBZhzNt sDBekC4vbTFhlC0ubjBcizBcjSEhdzJimiwsbTJmoHOt7yorbyw/VEKV8C5Rdx4eeCkpcS5LbSUm d2el7DRvsk+a7i8xdCxFXziL5jJnoy9Tey5SeTBYhC8wbjE0biMjdSkqdB8fdywtdy1CXScocDiO 7y5PdjeI4yYncjFdjyxAVSxGYjI0djI1czNsrTJkmy0ubS9QdCAgdkiX8DVxtnuy8JbE9i5JZzEy c0OV7zeL6HKw84G49X219DaD14m89DV3wTiO7Hmz9Fmb6ZDB9jc4c3mx8UqY8Gip8DQ1cTiH4Fag 8SYneDVyuzAxcTAycS1CWVyi8W+t8mSj7CIidFWd7UqU6VOc7Vie7XWy8zs9dHew8DI4bFOa6jyK 5UGR6pbD9lic6mOm8l+j7lWb6jBekS1LajJppjEzdDI0dSs8US4ubC0tbTJppDFaif///////yH5 BAEAAH8ALAAAAAAbABQAAAf/gH8eMGM3Hxd7iYqLjBo3QX+CLh8aFz96mJmam5gXHxV/MDN7elRS VUREahmsGVdyZ2RmJCRuQywsLx4uGnppRVNhYCRCSBzHHDQnJzZZNlA0Iy0lLqNYb0tNPXZ8C958 4HwKDuQOIyMLKkcvF3ptRUkIGCjgdvb3dgr6+nYJK0cx9kAQ4+SJj3AIuSEMZ4dOgDsFBIpgMsTC AgwY/Gj0Y0Dexo4LGqqAKDGKg44I/NDpM2DABAMqWar0YecBEJIQRKBxEMGABT8D+mhsEAFoHxxA 6fARAAJPgR8Q4Cjp8SBBAj8BBCANQAGrgKsBJqBoYMSpBAZs4iig8OCB0I01shq89XMg64IVOswy mKMFhYAJEwQcSNGhRocVggmnOEABQQAZestYQdCncp8GdQMckItZ84DGHb7sKHCWixALQQVYXr36 rwEDRnLsiHG2xQkKKgY8oENnN+8IwK36TAAkh4w7AD4wYLEGhAkddUCAqEO9uvU6Jjbk4VGiQgUN Xby02EA+j/nz6NGb4HFni6AKL0rcmU9/Pp77+PNDDAEj0p8gIRAg4IADAmDggQeGAEokgQAAOw== ------=_NextPart_000_0084_01C7B8B5.99126760 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://www.atsdr.cdc.gov/css/atsdr_main.css .m4 { =09 } TABLE.form CAPTION { BORDER-TOP-WIDTH: 1px; PADDING-RIGHT: 0px; PADDING-LEFT: 4px; = FONT-WEIGHT: bold; BORDER-LEFT-WIDTH: 1px; FONT-SIZE: 1.3em; = BORDER-BOTTOM-WIDTH: 1px; PADDING-BOTTOM: 3px; COLOR: #fff; PADDING-TOP: = 2px; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; = BACKGROUND-COLOR: #0066cc; TEXT-ALIGN: left; BORDER-RIGHT-WIDTH: 1px } TABLE.form CAPTION SPAN.right { PADDING-LEFT: 335px; FONT-SIZE: 0.7em; COLOR: #ffcc00 } TABLE.form { BORDER-RIGHT: #999999 1px solid; BORDER-TOP: #999999 1px solid; = BORDER-LEFT: #999999 1px solid; WIDTH: 98%; BORDER-BOTTOM: #999999 1px = solid; BORDER-COLLAPSE: collapse; border-spacing: 0; caption-side: top } TABLE.form TH { BORDER-TOP-WIDTH: 1px; PADDING-RIGHT: 4px; PADDING-LEFT: 4px; = BORDER-LEFT-WIDTH: 1px; FONT-SIZE: 1.1em; BORDER-BOTTOM-WIDTH: 1px; = PADDING-BOTTOM: 4px; PADDING-TOP: 4px; FONT-FAMILY: Arial, Helvetica, = sans-serif; BACKGROUND-COLOR: #e8e8e8; TEXT-ALIGN: center; = BORDER-RIGHT-WIDTH: 1px } TABLE.form TH.sort { FONT-SIZE: 90%; TEXT-ALIGN: left } TABLE.styled_border { BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px solid; = BORDER-LEFT: black 1px solid; WIDTH: 98%; BORDER-BOTTOM: black 1px solid } #cnt_wrap DIV.disclaimer { BORDER-RIGHT: #cc7f7f 1px solid; PADDING-RIGHT: 12px; BORDER-TOP: = #cc7f7f 1px solid; PADDING-LEFT: 12px; BACKGROUND: #fef6f6; = PADDING-BOTTOM: 0px; BORDER-LEFT: #cc7f7f 1px solid; PADDING-TOP: 0px; = BORDER-BOTTOM: #cc7f7f 1px solid } #cnt_wrap DIV.disclaimer P { MARGIN-TOP: 12px; MARGIN-BOTTOM: 12px; COLOR: #9b0000 } .note { FONT-SIZE: 95%; COLOR: #111111; FONT-FAMILY: Arial, Helvetica, = sans-serif } .description_note { FONT-SIZE: 95%; COLOR: #666666; FONT-FAMILY: Arial, Helvetica, = sans-serif } .nochildtitle { FONT-WEIGHT: normal; FONT-SIZE: 95%; COLOR: #666666; FONT-FAMILY: = Arial, Helvetica, sans-serif } .site_description { FONT-SIZE: 95%; MARGIN-LEFT: 11px; COLOR: #666666; FONT-FAMILY: Arial, = Helvetica, sans-serif } .last_update { FONT-SIZE: 95%; MARGIN: 50px 0px 7px; COLOR: #666666; FONT-FAMILY: = Arial, Helvetica, sans-serif; TEXT-ALIGN: center } .questions { FONT-SIZE: 95%; MARGIN: 5px 0px; COLOR: #666666; FONT-FAMILY: Arial, = Helvetica, sans-serif; TEXT-ALIGN: center } .adobe_reader { FONT-SIZE: 93%; MARGIN: 0px 0px 35px; COLOR: #666666; FONT-FAMILY: = Arial, Helvetica, sans-serif; TEXT-ALIGN: left } H6.naer_note { FONT-WEIGHT: normal; FONT-SIZE: 95% } .espanol { FONT-SIZE: 95%; COLOR: #990000; FONT-STYLE: normal; FONT-FAMILY: Arial, = Helvetica, sans-serif } .note_espanol { MARGIN-LEFT: 30px } DIV.pha_search { PADDING-RIGHT: 0px; PADDING-LEFT: 30px; FONT-WEIGHT: bold; FONT-SIZE: = 1em; BACKGROUND-IMAGE: url(../HAC/PHA/images/pha_search_box.gif); = PADDING-BOTTOM: 0px; MARGIN-LEFT: 28px; WIDTH: 492px; COLOR: #666666; = PADDING-TOP: 0px; BACKGROUND-REPEAT: no-repeat; HEIGHT: 42px } DIV.pha_search INPUT { MARGIN-TOP: 7px } .sort_note { BORDER-RIGHT: #cccccc 1px dashed; PADDING-RIGHT: 2px; BORDER-TOP: = #cccccc 1px dashed; PADDING-LEFT: 5px; FONT-SIZE: 0.98em; MARGIN-BOTTOM: = 22px; PADDING-BOTTOM: 5px; BORDER-LEFT: #cccccc 1px dashed; WIDTH: = 360px; PADDING-TOP: 5px; BORDER-BOTTOM: #cccccc 1px dashed; = BACKGROUND-COLOR: #f0f0f0 } DIV.find_publication { FONT-SIZE: 0.85em } TABLE.sortable CAPTION { BORDER-TOP-WIDTH: 1px; PADDING-RIGHT: 0px; PADDING-LEFT: 4px; = FONT-WEIGHT: bold; BORDER-LEFT-WIDTH: 1px; FONT-SIZE: 1.3em; = BORDER-BOTTOM-WIDTH: 1px; PADDING-BOTTOM: 2px; COLOR: #fff; PADDING-TOP: = 2px; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; = BACKGROUND-COLOR: #0066cc; TEXT-ALIGN: left; BORDER-RIGHT-WIDTH: 1px } TABLE.sortable { BORDER-RIGHT: #999999 1px solid; BORDER-TOP: #999999 1px solid; = BORDER-LEFT: #999999 1px solid; WIDTH: 98%; BORDER-BOTTOM: #999999 1px = solid; BORDER-COLLAPSE: collapse; border-spacing: 0; caption-side: top } TABLE.sortable TH { BORDER-TOP-WIDTH: 1px; PADDING-RIGHT: 4px; PADDING-LEFT: 4px; = BORDER-LEFT-WIDTH: 1px; FONT-SIZE: 1.1em; BORDER-BOTTOM-WIDTH: 1px; = PADDING-BOTTOM: 0px; PADDING-TOP: 0px; FONT-FAMILY: Arial, Helvetica, = sans-serif; BACKGROUND-COLOR: #e8e8e8; TEXT-ALIGN: center; = BORDER-RIGHT-WIDTH: 1px } TABLE.sortable TH.sort { FONT-SIZE: 90%; TEXT-ALIGN: left } table_1 { BORDER-RIGHT: #999999 1px solid; BORDER-TOP: #999999 1px solid; = BORDER-LEFT: #999999 1px solid; WIDTH: 98%; BORDER-BOTTOM: #999999 1px = solid; BORDER-COLLAPSE: collapse; border-spacing: 0; caption-side: top } TH.1 { BORDER-TOP-WIDTH: 1px; PADDING-RIGHT: 4px; PADDING-LEFT: 4px; = BORDER-LEFT-WIDTH: 1px; FONT-SIZE: 1.2em; BORDER-BOTTOM-WIDTH: 1px; = PADDING-BOTTOM: 4px; PADDING-TOP: 4px; FONT-FAMILY: Arial, Helvetica, = sans-serif; BACKGROUND-COLOR: #e8e8e8; TEXT-ALIGN: center; = BORDER-RIGHT-WIDTH: 1px } TD.special { BORDER-RIGHT: #cccccc 1px solid; PADDING-RIGHT: 4px; BORDER-TOP: = #cccccc 1px solid; PADDING-LEFT: 4px; FONT-SIZE: 100%; PADDING-BOTTOM: = 4px; BORDER-LEFT: #cccccc 1px solid; PADDING-TOP: 4px; BORDER-BOTTOM: = #cccccc 1px solid; FONT-FAMILY: Arial, Helvetica, sans-serif; = TEXT-ALIGN: left } TD.special UL LI { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 8px; = PADDING-TOP: 0px; LIST-STYLE-TYPE: none } .table_pha { BORDER-RIGHT: #999999 1px solid; BORDER-TOP: #999999 1px solid; = BORDER-LEFT: #999999 1px solid; WIDTH: 98%; BORDER-BOTTOM: #999999 1px = solid; BORDER-COLLAPSE: collapse; border-spacing: 0; caption-side: top } TABLE.table_pha TH { BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 2px; PADDING-LEFT: 2px; = BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 1em; BORDER-LEFT-COLOR: #333333; = BORDER-BOTTOM-WIDTH: 0px; BORDER-BOTTOM-COLOR: #333333; PADDING-BOTTOM: = 2px; BORDER-TOP-COLOR: #333333; PADDING-TOP: 2px; FONT-FAMILY: Arial, = Helvetica, sans-serif; BACKGROUND-COLOR: #e8e8e8; TEXT-ALIGN: center; = BORDER-RIGHT-WIDTH: 0px; BORDER-RIGHT-COLOR: #333333 } TABLE.table_pha TH.layout { BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 2px; PADDING-LEFT: 2px; = BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 1em; BORDER-LEFT-COLOR: #333333; = BORDER-BOTTOM-WIDTH: 0px; BORDER-BOTTOM-COLOR: #333333; PADDING-BOTTOM: = 2px; BORDER-TOP-COLOR: #333333; PADDING-TOP: 2px; FONT-FAMILY: Arial, = Helvetica, sans-serif; BACKGROUND-COLOR: #e8e8e8; TEXT-ALIGN: left; = BORDER-RIGHT-WIDTH: 0px; BORDER-RIGHT-COLOR: #333333 } .table_pha CAPTION { BORDER-TOP-WIDTH: 1px; PADDING-RIGHT: 0px; PADDING-LEFT: 4px; = FONT-WEIGHT: bold; BORDER-LEFT-WIDTH: 1px; FONT-SIZE: 1.1em; = BORDER-BOTTOM-WIDTH: 1px; PADDING-BOTTOM: 1px; COLOR: #fff; PADDING-TOP: = 1px; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; = BACKGROUND-COLOR: #0066cc; TEXT-ALIGN: left; BORDER-RIGHT-WIDTH: 1px } .region_menu { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: = 13px; PADDING-BOTTOM: 40px; PADDING-TOP: 15px; FONT-FAMILY: Arial, = Helvetica, sans-serif; TEXT-ALIGN: center } .horizontal_menu { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: = 13px; PADDING-BOTTOM: 40px; PADDING-TOP: 15px; FONT-FAMILY: Arial, = Helvetica, sans-serif; TEXT-ALIGN: center } .table_marietta { border-spacing: 0; caption-side: top } .table_marietta CAPTION { BORDER-TOP-WIDTH: 1px; PADDING-RIGHT: 0px; PADDING-LEFT: 5px; = FONT-WEIGHT: bold; BORDER-LEFT-WIDTH: 1px; FONT-SIZE: 1em; = BORDER-BOTTOM-WIDTH: 1px; PADDING-BOTTOM: 3px; COLOR: #fff; PADDING-TOP: = 3px; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; = BACKGROUND-COLOR: #0066cc; TEXT-ALIGN: left; BORDER-RIGHT-WIDTH: 1px } TABLE.table_marietta TH { BORDER-TOP-WIDTH: 1px; PADDING-RIGHT: 0px; PADDING-LEFT: 4px; = BORDER-LEFT-WIDTH: 1px; FONT-SIZE: 1em; BORDER-BOTTOM-WIDTH: 1px; = PADDING-BOTTOM: 2px; VERTICAL-ALIGN: top; PADDING-TOP: 2px; FONT-FAMILY: = Arial, Helvetica, sans-serif; BACKGROUND-COLOR: #e8e8e8; TEXT-ALIGN: = center; BORDER-RIGHT-WIDTH: 1px } TABLE.table_marietta TD.small_font { FONT-SIZE: 0.95em; VERTICAL-ALIGN: top } TABLE.table_marietta TD UL { FONT-SIZE: 0.95em; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 15px; = LIST-STYLE-TYPE: circle } TABLE.table_marietta TD UL.normal { FONT-SIZE: 1em; MARGIN-LEFT: auto } TABLE.table_marietta TD UL LI { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 2px; = PADDING-TOP: 2px } TABLE.table_marietta TD UL LI.last { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; = PADDING-TOP: 2px } #container { BORDER-RIGHT: 0px; PADDING-RIGHT: 0px; BORDER-TOP: 0px; PADDING-LEFT: = 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; BORDER-LEFT: 0px; WIDTH: 760px; = PADDING-TOP: 0px; BORDER-BOTTOM: 0px } #container_ice { BORDER-RIGHT: 0px; PADDING-RIGHT: 0px; BORDER-TOP: 0px; PADDING-LEFT: = 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; BORDER-LEFT: 0px; WIDTH: 100%; = PADDING-TOP: 0px; BORDER-BOTTOM: 0px } #banner { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; MARGIN-BOTTOM: 12px; = PADDING-BOTTOM: 0px; PADDING-TOP: 0px } #banner_ice { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND-IMAGE: = url(../images/atsdr_header_bg_image.gif); MARGIN-BOTTOM: 12px; = PADDING-BOTTOM: 0px; PADDING-TOP: 0px; BACKGROUND-REPEAT: repeat-x } #content { PADDING-RIGHT: 0px; BORDER-TOP: #e5e5e5 1px solid; PADDING-LEFT: 12px; = PADDING-BOTTOM: 20px; MARGIN-LEFT: 176px; BORDER-LEFT: #e5e5e5 1px = solid; MARGIN-RIGHT: 197px; PADDING-TOP: 0px; BACKGROUND-COLOR: #fff } #content_subpage { PADDING-RIGHT: 0px; BORDER-TOP: #e5e5e5 1px solid; PADDING-LEFT: 12px; = PADDING-BOTTOM: 20px; MARGIN-LEFT: 176px; BORDER-LEFT: #e5e5e5 1px = solid; MARGIN-RIGHT: 20px; PADDING-TOP: 0px; BACKGROUND-COLOR: #fff } #sidebar-a { PADDING-RIGHT: 0px; PADDING-LEFT: 12px; FLOAT: left; PADDING-BOTTOM: = 0px; MARGIN-LEFT: 0px; WIDTH: 160px; MARGIN-RIGHT: 0px; PADDING-TOP: = 0px; BACKGROUND-COLOR: #fff } #sidebar-b { PADDING-RIGHT: 0px; PADDING-LEFT: 10px; FLOAT: right; PADDING-BOTTOM: = 0px; MARGIN: 0px; WIDTH: 186px; PADDING-TOP: 0px; BACKGROUND-COLOR: #fff } #footer { CLEAR: both; PADDING-RIGHT: 0px; MARGIN-TOP: 0px; PADDING-LEFT: 0px; = PADDING-BOTTOM: 0px; PADDING-TOP: 0px; BACKGROUND-COLOR: #fff } #footer_ice { CLEAR: both; PADDING-RIGHT: 0px; MARGIN-TOP: 0px; PADDING-LEFT: 0px; = BACKGROUND-IMAGE: url(../images/atsdr_footer_bg_image.gif); = PADDING-BOTTOM: 0px; PADDING-TOP: 0px; BACKGROUND-REPEAT: repeat-x; = BACKGROUND-COLOR: #fff } FORM { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; PADDING-TOP: 0px } BODY { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: normal; FONT-SIZE: = 0.75em; BACKGROUND: url(../images/bgMain.gif) #ffffff fixed 0px 50%; = PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; FONT-STYLE: normal; = FONT-FAMILY: Arial, Helvetica, sans-serif; FONT-VARIANT: normal } BODY.ice { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: normal; FONT-SIZE: = 0.75em; BACKGROUND: none transparent scroll repeat 0% 0%; = PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; FONT-STYLE: normal; = FONT-FAMILY: Arial, Helvetica, sans-serif; FONT-VARIANT: normal } A { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #003366; = TEXT-DECORATION: underline } A:hover { TEXT-DECORATION: none } P { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } SPAN { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } UL { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } LI { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } .tE { FONT: 95% bold Arial, Helvetica, sans-serif } .exlnknote { FONT-SIZE: 95%; COLOR: #000000 } .breadcrumbs { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 95%; PADDING-BOTTOM: = 0px; MARGIN: 0.4em 0px; PADDING-TOP: 0px } .breadcrumbs OL { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; PADDING-TOP: 0px } .breadcrumbs LI { DISPLAY: inline; COLOR: #000 } .breadcrumbs A { COLOR: #000 } #cnttopnav { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; FONT: 12px Arial, Helvetica, sans-serif; BORDER-TOP-STYLE: none; = PADDING-TOP: 0px; BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; = BACKGROUND-COLOR: #fff; BORDER-BOTTOM-STYLE: none } #cnttopnav H1 { PADDING-RIGHT: 0px; PADDING-LEFT: 10px; FONT-WEIGHT: bold; FONT-SIZE: = 120%; PADDING-BOTTOM: 2px; MARGIN: 0px; COLOR: #fff; PADDING-TOP: 3px; = BACKGROUND-COLOR: #009966 } #cnttopnav H2 { PADDING-RIGHT: 0px; PADDING-LEFT: 4px; FONT-WEIGHT: bold; FONT-SIZE: = 120%; PADDING-BOTTOM: 2px; MARGIN: 0px; COLOR: #fff; PADDING-TOP: 3px; = BACKGROUND-COLOR: #009966 } #cnttopnav H3 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: = 115%; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: #000; PADDING-TOP: 0px; = BACKGROUND-COLOR: #fff } #cnttopnav .h3sm { FONT-WEIGHT: bold; FONT-SIZE: 90%; COLOR: #000 } #cnttopnavlist { PADDING-LEFT: 0px; FONT-SIZE: 100%; LIST-STYLE-IMAGE: = url(../images/blt.gif); MARGIN: 0.5em 0.5em 0px 25px; LIST-STYLE-TYPE: = square } #cnttopnavlist LI { PADDING-LEFT: 0px; FONT-SIZE: 100%; MARGIN-BOTTOM: 0.3em; MARGIN-LEFT: = 0px } #cnttopnavlist A { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #003366; = TEXT-DECORATION: underline } #cnttopnavlist A:hover { TEXT-DECORATION: none } #cnttopnav IMG.thumb { BORDER-RIGHT: #999999 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: = #999999 1px solid; MARGIN-TOP: 6px; PADDING-LEFT: 0px; FLOAT: right; = PADDING-BOTTOM: 0px; MARGIN-LEFT: 4px; BORDER-LEFT: #999999 1px solid; = PADDING-TOP: 0px; BORDER-BOTTOM: #999999 1px solid } #cnttopnav .pdf_dwnld { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 95%; PADDING-BOTTOM: = 0px; MARGIN: 5px 0px; COLOR: #ff0000; PADDING-TOP: 0px; TEXT-ALIGN: = right } #cnttopnav .pdf_dwnld A { FONT-SIZE: 95%; COLOR: #ff0000; TEXT-DECORATION: underline } #globalnav { BACKGROUND: #000; PADDING-BOTTOM: 3px; MARGIN: 0px; WIDTH: 760px; = COLOR: #fff; PADDING-TOP: 3px; HEIGHT: 14px } #globalnav_ice { BACKGROUND: #000; PADDING-BOTTOM: 3px; MARGIN: 0px; WIDTH: 100%; COLOR: = #fff; PADDING-TOP: 3px; HEIGHT: 14px } #globalnav UL { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; COLOR: #fff; PADDING-TOP: 0px; WHITE-SPACE: nowrap } #globalnav LI { BORDER-RIGHT: #fff 1px solid; PADDING-RIGHT: 8px; DISPLAY: inline; = PADDING-LEFT: 8px; MARGIN: 0px; LIST-STYLE-TYPE: none; TEXT-ALIGN: = center } #globalnav LI.last { PADDING-RIGHT: 8px; DISPLAY: inline; PADDING-LEFT: 8px; MARGIN: 0px; = BORDER-RIGHT-STYLE: none; LIST-STYLE-TYPE: none; TEXT-ALIGN: center } #globalnav LI A { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT: 95% Arial, Verdana, = Helvetica, sans-serif; COLOR: #fff; TEXT-ALIGN: center; TEXT-DECORATION: = underline } #globalnav LI A:hover { TEXT-DECORATION: none } #headerwrap { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; WIDTH: 760px; BORDER-TOP-STYLE: none; PADDING-TOP: 0px; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; BACKGROUND-COLOR: = #fff; BORDER-BOTTOM-STYLE: none } #header { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND-IMAGE: = url(../images/bgHdr.gif); PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: = 760px; PADDING-TOP: 0px } #header .logo { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; PADDING-TOP: 0px; HEIGHT: 71px } .logo IMG { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 8px; MARGIN: = 0px; PADDING-TOP: 8px } #header .spanish { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: = url(../images/hr_search.gif) fixed no-repeat 50% bottom; LEFT: 559px; = PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 189px; COLOR: #ffffff; = PADDING-TOP: 0px; POSITION: absolute; TOP: 29px; HEIGHT: 22px; = TEXT-ALIGN: right } #header .spanish A { FONT-SIZE: 12px; COLOR: #ffffff; TEXT-ALIGN: right } #header .form { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; LEFT: 559px; PADDING-BOTTOM: = 0px; MARGIN: 0px; WIDTH: 189px; COLOR: #ffffff; PADDING-TOP: 0px; = POSITION: absolute; TOP: 59px; HEIGHT: 20px } #header .form P { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; COLOR: #ffffff; PADDING-TOP: 0px; TEXT-ALIGN: right } #header .form INPUT[type=3Dtext] { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; PADDING-TOP: 0px } #header .form INPUT[type=3Dimage] { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; PADDING-TOP: 0px } #header .form FORM { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; PADDING-TOP: 0px } .searchButton { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; = VERTICAL-ALIGN: bottom; PADDING-TOP: 0px } #leftnav { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; WIDTH: 160px; BORDER-TOP-STYLE: none; PADDING-TOP: 0px; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; BACKGROUND-COLOR: = #fff; BORDER-BOTTOM-STYLE: none } #topicnav H2 { PADDING-RIGHT: 0px; PADDING-LEFT: 8px; FONT-WEIGHT: bold; FONT-SIZE: = 110%; PADDING-BOTTOM: 4px; MARGIN: 0px; COLOR: #000; PADDING-TOP: 4px; = BACKGROUND-COLOR: #ffecb9 } #topicnav { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; PADDING-TOP: 0px; BACKGROUND-COLOR: #ffffe5 } #topiclist { PADDING-RIGHT: 1px; PADDING-LEFT: 1px; BACKGROUND: #ffffe5; = PADDING-BOTTOM: 1px; MARGIN: 0px; PADDING-TOP: 0px } #topiclist LI { PADDING-LEFT: 15px; BACKGROUND: url(../images/blt.gif) no-repeat 0.7em = 0.7em; MARGIN: 0px; BORDER-BOTTOM: #e5e5ce 1px solid; LIST-STYLE-TYPE: = none; TEXT-ALIGN: left } #topiclist LI.search { BORDER-TOP: #e5e5ce 1px solid; PADDING-LEFT: 5px; FONT-SIZE: 0.94em; = BACKGROUND: none transparent scroll repeat 0% 0%; PADDING-BOTTOM: 2px; = MARGIN: 0px; PADDING-TOP: 1px; BORDER-BOTTOM: #e5e5ce 1px solid; = LIST-STYLE-TYPE: none; TEXT-ALIGN: left } #topiconlist LI.search { PADDING-LEFT: 5px; FONT-SIZE: 0.94em; BACKGROUND: none transparent = scroll repeat 0% 0%; PADDING-BOTTOM: 10px; MARGIN: 0px; PADDING-TOP: = 1px; LIST-STYLE-TYPE: none; TEXT-ALIGN: left } #topiconlist2 LI.search { PADDING-LEFT: 5px; FONT-SIZE: 0.94em; BACKGROUND: none transparent = scroll repeat 0% 0%; PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; = LIST-STYLE-TYPE: none; TEXT-ALIGN: left } UL.topiclist2 { MARGIN-TOP: 2px; MARGIN-BOTTOM: 2px } UL.topiclist2 LI { PADDING-LEFT: 20px; BACKGROUND: url(../images/blt.gif) no-repeat 0.7em = 0.7em; MARGIN: 3px 0px; LIST-STYLE-TYPE: none; TEXT-ALIGN: left } #topiclist LI.first { BORDER-TOP: #e5e5ce 1px solid } #topiclist LI.last { BORDER-BOTTOM-WIDTH: 0px } #topiclist LI A { PADDING-RIGHT: 0.5em; DISPLAY: block; PADDING-LEFT: 0.75em; BACKGROUND: = #ffffe5; PADDING-BOTTOM: 0.18em; PADDING-TOP: 0.18em; TEXT-DECORATION: = underline } #topiclist LI A:hover { BORDER-LEFT-COLOR: #ffffe5; BACKGROUND: #ffffe5; BORDER-BOTTOM-COLOR: = #ffffe5; BORDER-TOP-COLOR: #ffffe5; TEXT-DECORATION: none; = BORDER-RIGHT-COLOR: #ffffe5 } .ctrlink { MARGIN-BOTTOM: 0px } .divlink { MARGIN-TOP: -5px } .hr_tp { MARGIN-TOP: 5px; BACKGROUND: url(../images/div_hrz_blackdot3.gif) #fff = no-repeat center 50%; WIDTH: 160px; HEIGHT: 15px } .hr_btm { MARGIN-TOP: 0px; BACKGROUND: url(../images/div_hrz_blackdot3.gif) #fff = no-repeat center 50%; WIDTH: 160px; HEIGHT: 15px } #metrics { BORDER-TOP: #e5e5e5 1px solid; MARGIN: 0px; WIDTH: 760px; HEIGHT: 20px; = BACKGROUND-COLOR: #fff } #btmnav { PADDING-RIGHT: 0px; BORDER-TOP: #ccc 1px solid; PADDING-LEFT: 0px; = BACKGROUND: #f5f5f5; PADDING-BOTTOM: 4px; MARGIN: 0px; WIDTH: 760px; = PADDING-TOP: 4px; BORDER-BOTTOM: #ccc 1px solid; BORDER-RIGHT-STYLE: = none; BORDER-LEFT-STYLE: none; HEIGHT: 15px } #btmnav_ice { PADDING-RIGHT: 0px; BORDER-TOP: #ccc 1px solid; PADDING-LEFT: 0px; = BACKGROUND: #f5f5f5; PADDING-BOTTOM: 4px; MARGIN: 0px; WIDTH: 100%; = PADDING-TOP: 4px; BORDER-BOTTOM: #ccc 1px solid; BORDER-RIGHT-STYLE: = none; BORDER-LEFT-STYLE: none; HEIGHT: 15px } #btmnav UL { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; PADDING-TOP: 0px } #btmnav LI { BORDER-RIGHT: #000 1px solid; PADDING-RIGHT: 7px; DISPLAY: inline; = PADDING-LEFT: 8px; PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; = BORDER-LEFT-STYLE: none; LIST-STYLE-TYPE: none; TEXT-ALIGN: center } #btmnav LI.last { PADDING-RIGHT: 7px; DISPLAY: inline; PADDING-LEFT: 8px; PADDING-BOTTOM: = 0px; MARGIN: 0px; PADDING-TOP: 0px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; LIST-STYLE-TYPE: none; TEXT-ALIGN: center } #btmnav LI A { FONT: 0.9em Arial, Verdana, Helvetica, sans-serif; COLOR: #003366; = TEXT-ALIGN: center; TEXT-DECORATION: underline } #btmnav UL LI A:hover { TEXT-DECORATION: none } #ftrwrap { BORDER-TOP: #e5e5e5 1px solid; MARGIN: 0px; WIDTH: 760px; PADDING-TOP: = 20px; BACKGROUND-COLOR: #fff } #ftr { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: #e5e5e5; = PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 760px; PADDING-TOP: 0px; = HEIGHT: 60px } #ftr_ice { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: #e5e5e5; = PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 100%; PADDING-TOP: 0px; HEIGHT: = 60px } #ftr .float1 { PADDING-RIGHT: 0px; PADDING-LEFT: 8px; BACKGROUND: #e5e5e5; FLOAT: = left; PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 400px; PADDING-TOP: 10px } #ftr .float1 IMG { BORDER-RIGHT: 0px; BORDER-TOP: 0px; PADDING-BOTTOM: 10px; MARGIN: 0px; = BORDER-LEFT: 0px; BORDER-BOTTOM: 0px } #ftr .float2 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: #e5e5e5; FLOAT: = left; PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 147px; PADDING-TOP: 5px } #ftr .float2 IMG { BORDER-RIGHT: 0px; PADDING-RIGHT: 0px; BORDER-TOP: 0px; PADDING-LEFT: = 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; BORDER-LEFT: 0px; PADDING-TOP: = 0px; BORDER-BOTTOM: 0px } #ftr .float3 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: #e5e5e5; FLOAT: = left; PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 205px; PADDING-TOP: 5px } #ftr .float3 A { FONT-SIZE: 11px } #ftr .float3 IMG { BORDER-RIGHT: 0px; PADDING-RIGHT: 0px; BORDER-TOP: 0px; PADDING-LEFT: = 0px; FLOAT: left; PADDING-BOTTOM: 0px; MARGIN: 0px; BORDER-LEFT: 0px; = PADDING-TOP: 0px; BORDER-BOTTOM: 0px } #ftr .txtftrBottom { FONT-SIZE: 9px; LINE-HEIGHT: 1em } #contentnav { BORDER-RIGHT: #e5e5e5 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: = #e5e5e5 1px solid; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; = BORDER-LEFT: #e5e5e5 1px solid; WIDTH: 365px; PADDING-TOP: 0px; = BORDER-BOTTOM: #e5e5e5 1px solid; BACKGROUND-COLOR: #fff } #contentnav H2 { PADDING-RIGHT: 0px; PADDING-LEFT: 4px; FONT-WEIGHT: bold; FONT-SIZE: = 110%; PADDING-BOTTOM: 5px; MARGIN: 0px; COLOR: #ffffff; PADDING-TOP: = 5px; BACKGROUND-COLOR: #006633 } #contentnavlist { PADDING-LEFT: 0px; FONT-SIZE: 100%; LIST-STYLE-IMAGE: = url(../images/blt2.gif); MARGIN: 0.5em 0.5em 0px 25px; LIST-STYLE-TYPE: = square } #contentnavlist LI { PADDING-LEFT: 0px; FONT-SIZE: 100%; MARGIN-BOTTOM: 0.5em; MARGIN-LEFT: = 0px } #contentnavlist A { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #003366; = TEXT-DECORATION: underline } #contentnavlist A:hover { TEXT-DECORATION: none } #contentnavlist A.tE { FONT-WEIGHT: bold } #spotlight { BORDER-RIGHT: #e5e5e5 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: = #e5e5e5 1px solid; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; = BORDER-LEFT: #e5e5e5 1px solid; WIDTH: 365px; PADDING-TOP: 0px; = BORDER-BOTTOM: #e5e5e5 1px solid; BACKGROUND-COLOR: #ffffe5 } #spotlight H2 { PADDING-RIGHT: 0px; PADDING-LEFT: 10px; FONT-WEIGHT: bold; FONT-SIZE: = 120%; PADDING-BOTTOM: 2px; MARGIN: 0px; COLOR: #ffffff; PADDING-TOP: = 3px; BACKGROUND-COLOR: #009966 } UL#newslist { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 95%; PADDING-BOTTOM: = 0px; MARGIN: 0px 1.1em 0px 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none } #newslist LI { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; PADDING-TOP: 0px; HEIGHT: 76px } #newslist LI.last { PADDING-BOTTOM: 0px } #newslist IMG.thumb { BORDER-RIGHT: #999999 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: = #999999 1px solid; PADDING-LEFT: 0px; FLOAT: left; PADDING-BOTTOM: 0px; = BORDER-LEFT: #999999 1px solid; MARGIN-RIGHT: 10px; PADDING-TOP: 0px; = BORDER-BOTTOM: #999999 1px solid } #newslist .home_spotlight { BORDER-RIGHT: #999999 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: = #999999 1px solid; PADDING-LEFT: 0px; BACKGROUND: white; FLOAT: left; = PADDING-BOTTOM: 0px; BORDER-LEFT: #999999 1px solid; WIDTH: 110px; = MARGIN-RIGHT: 10px; PADDING-TOP: 3px; BORDER-BOTTOM: #999999 1px solid; = HEIGHT: 71px } #newslist A { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #003366; = TEXT-DECORATION: underline } #newslist A:hover { TEXT-DECORATION: none } #newslist P { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } SPAN { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } #spotlight A.tE { FONT: bold 100% Arial, Helvetica, sans-serif; COLOR: #003366; = TEXT-DECORATION: underline } #spotlight A.tE:hover { TEXT-DECORATION: none } #newslist A.tE { FONT-WEIGHT: bold } #spotlight UL.thumblist { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 95%; PADDING-BOTTOM: = 0px; MARGIN: 1.1em 1.1em 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none } #content P { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } SPAN { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } UL { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } LI { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } #content P.update { FONT-WEIGHT: bold; COLOR: #ff0000; TEXT-ALIGN: right } #content A { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #003366; = TEXT-DECORATION: underline } #content A:hover { TEXT-DECORATION: none } #content A.tE { FONT-WEIGHT: bold } #content .banner { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; MARGIN-BOTTOM: 10px; = PADDING-BOTTOM: 0px; PADDING-TOP: 0px; TEXT-ALIGN: left } #content .banner IMG { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; MARGIN-BOTTOM: 0px; = PADDING-BOTTOM: 0px; PADDING-TOP: 0px; BORDER-BOTTOM: #e5e5e5 2px solid } #content_subpage P { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } SPAN { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } UL { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } LI { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } #content_subpage P.update { FONT-WEIGHT: bold; COLOR: #ff0000; TEXT-ALIGN: right } #content_subpage A { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #003366; = TEXT-DECORATION: underline } #content_subpage A:hover { TEXT-DECORATION: none } #content_subpage A.tE { FONT-WEIGHT: bold } #content_subpage .banner { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; MARGIN-BOTTOM: 10px; = PADDING-BOTTOM: 0px; PADDING-TOP: 0px; TEXT-ALIGN: left } #content_subpage .banner IMG { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; MARGIN-BOTTOM: 0px; = PADDING-BOTTOM: 0px; PADDING-TOP: 0px; BORDER-BOTTOM: #e5e5e5 2px solid } #cnt_wrap UL#contentlist UL.list { PADDING-LEFT: 0px; FONT-SIZE: 100%; LIST-STYLE-IMAGE: = url(../images/blt.gif); MARGIN: 0px 0px 0px 40px; LIST-STYLE-TYPE: = square } #cnt_wrap UL#contentlist UL LI { PADDING-LEFT: 0px; FONT-SIZE: 100%; MARGIN-LEFT: 0px; LIST-STYLE-TYPE: = square } #cnt_wrap UL#contentlist { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; PADDING-BOTTOM: = 0px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none } #cnt_wrap UL#contentlist LI { FONT-SIZE: 100%; MARGIN-BOTTOM: 0.5em; PADDING-TOP: 5px } #cnt_wrap UL#contentlist LI.last { PADDING-BOTTOM: 5px } #cnt_wrap UL#contentlist LI A.tE { FONT-SIZE: 100% } .spacer2 { BACKGROUND-POSITION: left top; BACKGROUND-IMAGE: url(../images/s.gif); = VERTICAL-ALIGN: top; WIDTH: 1px; BACKGROUND-REPEAT: no-repeat; HEIGHT: = 5px; TEXT-ALIGN: center } .hr { MARGIN-TOP: 5px; BACKGROUND: url(../images/div_hrz_blackdot3.gif) #fff = no-repeat center 50%; MARGIN-LEFT: 5px; WIDTH: 353px; HEIGHT: 15px } #cnt_wrap { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; FONT: 1em Arial, Helvetica, sans-serif; BORDER-TOP-STYLE: none; = PADDING-TOP: 0px; BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; = BACKGROUND-COLOR: #fff; BORDER-BOTTOM-STYLE: none } #cnt_wrap H2 { PADDING-RIGHT: 0px; PADDING-LEFT: 4px; FONT-WEIGHT: bold; FONT-SIZE: = 120%; PADDING-BOTTOM: 2px; MARGIN: 0px; COLOR: #fff; PADDING-TOP: 3px; = BACKGROUND-COLOR: #006633 } #cnt_wrap H3 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: = 115%; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: #000; PADDING-TOP: 0px; = BACKGROUND-COLOR: #fff } #cnt_wrap H4 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: = 110%; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: #000; PADDING-TOP: 0px; = BACKGROUND-COLOR: #fff } #cnt_wrap H5 { FONT-WEIGHT: bold; FONT-SIZE: 100%; MARGIN-BOTTOM: -10px; COLOR: #000; = PADDING-TOP: 0px; BACKGROUND-COLOR: #fff } #cnt_wrap .pdf_dwnld { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 95%; PADDING-BOTTOM: = 0px; MARGIN: 5px 0px; COLOR: #ff0000; PADDING-TOP: 0px; TEXT-ALIGN: = right } #cnt_wrap .pdf_dwnld A { FONT-SIZE: 95%; COLOR: #ff0000; TEXT-DECORATION: underline } #cnt_wrap .usmap { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; PADDING-TOP: 10px; TEXT-ALIGN: center } #cnt_wrap .usmap A { DISPLAY: block; FONT-SIZE: 95%; MARGIN-BOTTOM: 5px; TEXT-ALIGN: right; = TEXT-DECORATION: underline } #cnt_wrap A.anchortag { PADDING-RIGHT: 1px; PADDING-LEFT: 1px; FONT-WEIGHT: bold; FONT-SIZE: = 1.5em; PADDING-BOTTOM: 1px; COLOR: #0066cc; PADDING-TOP: 1px; = FONT-FAMILY: Verdana, Arial, Helvetica, Verdana, sans-serif; = TEXT-DECORATION: none } .top { FONT-SIZE: 95%; MARGIN: 0px 0px 35px; TEXT-ALIGN: right } .top A { TEXT-DECORATION: underline } #cnt_wrap .legendbox { BORDER-RIGHT: #e5e5e5 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: = #e5e5e5 1px solid; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; = BORDER-LEFT: #e5e5e5 1px solid; PADDING-TOP: 0px; BORDER-BOTTOM: #e5e5e5 = 1px solid; BACKGROUND-COLOR: #fff } #cnt_wrap UL#lgndlist { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 95%; PADDING-BOTTOM: = 0px; MARGIN: 0.6em; PADDING-TOP: 0px; LIST-STYLE-TYPE: none } #lgndlist LI { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; = PADDING-BOTTOM: 6px; MARGIN: 0px; PADDING-TOP: 0px } #lgndlist LI.last { PADDING-BOTTOM: 0px } #lgndlist IMG.lgnd { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FLOAT: left; MARGIN-BOTTOM: 6px; = PADDING-BOTTOM: 0px; MARGIN-RIGHT: 4px; PADDING-TOP: 0px } #rightnav { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; WIDTH: 169px; BORDER-TOP-STYLE: none; PADDING-TOP: 0px; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; BACKGROUND-COLOR: = #fff; BORDER-BOTTOM-STYLE: none } #topiconlist { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; PADDING-BOTTOM: = 0px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none } #topiconlist2 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; PADDING-BOTTOM: = 0px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none } #topiconlist LI { PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 100%; = PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 2px; LIST-STYLE-TYPE: = none } #topiconlist2 LI { PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 100%; = PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 2px; LIST-STYLE-TYPE: = none } #topiconlist LI.first { PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 100%; = PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px } #topiconlist LI.last { PADDING-BOTTOM: 10px } #topiconlist2 LI.last { PADDING-BOTTOM: 10px } #topiconlist IMG.icon { PADDING-RIGHT: 0px; MARGIN-TOP: 3px; PADDING-LEFT: 0px; FLOAT: left; = PADDING-BOTTOM: 0px; MARGIN-RIGHT: 8px; PADDING-TOP: 0px } #topiclist LI A { PADDING-RIGHT: 0.5em; DISPLAY: block; PADDING-LEFT: 0.75em; BACKGROUND: = #ffffe5; PADDING-BOTTOM: 0.18em; PADDING-TOP: 0.18em; TEXT-DECORATION: = underline } #rightnavlist1 { PADDING-LEFT: 0px; FONT-SIZE: 100%; LIST-STYLE-IMAGE: = url(../images/blt.gif); MARGIN: 0.5em 0.5em 0px 24px } #rightnavlist1 LI { PADDING-LEFT: 0px; FONT-SIZE: 100%; MARGIN-BOTTOM: 0.5em; MARGIN-LEFT: = 0.4em } #rightnavlist1 A { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #003366; = TEXT-DECORATION: underline } #rightnavlist1 A:hover { TEXT-DECORATION: none } #rightnavlist1 A.tE { FONT-WEIGHT: bold } #rightnavlist1 LI.last { PADDING-BOTTOM: 5px } #rightnavlist2 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; PADDING-BOTTOM: = 0px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none } #rightnavlist2 LI { FONT-SIZE: 100%; PADDING-BOTTOM: 10px; MARGIN: 0px; PADDING-TOP: 5px } #rightnavlist2 A { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #003366; = TEXT-DECORATION: underline } #rightnavlist2 A:hover { TEXT-DECORATION: none } #rightnavlist2 A.tE { FONT-WEIGHT: bold } #rightnavlist3 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; PADDING-BOTTOM: = 0px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none } #rightnavlist3 LI { FONT-SIZE: 100%; MARGIN-BOTTOM: 0.5em; PADDING-TOP: 5px } #rightnavlist3 LI.last { PADDING-BOTTOM: 5px } #rightnavlist3 A { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #003366; = TEXT-DECORATION: underline } #rightnavlist3 A:hover { TEXT-DECORATION: none } #rightnavlist3 A.tE { FONT-WEIGHT: bold } #rightnavlist0 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; BACKGROUND: = #fff; PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px } #rightnavlist0 LI { PADDING-LEFT: 14px; FONT-SIZE: 100%; BACKGROUND: url(../images/blt.gif) = no-repeat left top; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1.2em; = LIST-STYLE-TYPE: none; TEXT-ALIGN: left } #rightnavlist0 LI A { MARGIN-TOP: 0.6em; DISPLAY: block; PADDING-LEFT: 0px; BACKGROUND: #fff; = MARGIN-BOTTOM: 0px; FONT: 100% Arial, Helvetica, sans-serif; COLOR: = #003366; TEXT-DECORATION: underline } #rightnavlist0 LI A.last { MARGIN-TOP: 0.4em; PADDING-LEFT: 0px; MARGIN-BOTTOM: 0px } #rightnavlist0 A:hover { TEXT-DECORATION: none } #rightnavlist0 A.tE { FONT-WEIGHT: bold } .rightnavheading { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; PADDING-TOP: 0px } .hr_1 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: = url(../images/div_hrz_blackdot3.gif) #fff no-repeat 50% top; = PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 160px; PADDING-TOP: 0px; = HEIGHT: 5px } .hr_1_m3 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: = url(../images/div_hrz_blackdot3.gif) #fff no-repeat 50% top; = MARGIN-BOTTOM: -8px; PADDING-BOTTOM: 0px; WIDTH: 160px; PADDING-TOP: 0px } .hr_2 { MARGIN-TOP: -8px; BACKGROUND: url(../images/div_hrz_blackdot3.gif) #fff = no-repeat center 50%; MARGIN-BOTTOM: 5px; WIDTH: 160px; HEIGHT: 15px } .hr_2_1 { MARGIN-TOP: -8px; BACKGROUND: url(../images/div_hrz_blackdot3.gif) #fff = no-repeat center 50%; MARGIN-BOTTOM: 0px; WIDTH: 160px; HEIGHT: 2px } .hr_3 { MARGIN-TOP: 5px; BACKGROUND: url(../images/div_hrz_blackdot3.gif) #fff = no-repeat center 50%; MARGIN-BOTTOM: 5px; WIDTH: 160px; HEIGHT: 15px } .hr_4 { MARGIN-TOP: -5px; BACKGROUND: url(../images/div_hrz_blackdot3.gif) #fff = no-repeat center 50%; MARGIN-BOTTOM: 5px; WIDTH: 160px; HEIGHT: 15px } .hr_5 { MARGIN-TOP: -5px; BACKGROUND: url(../images/div_hrz_blackdot3.gif) #fff = no-repeat center 50%; MARGIN-BOTTOM: 0px; WIDTH: 160px; HEIGHT: 15px } .smallblob { MARGIN-TOP: 3px; FONT-WEIGHT: normal; FONT-SIZE: 0.95em; COLOR: = #003366; FONT-FAMILY: Arial, Helvetica, sans-serif } HR { DISPLAY: none } #skipnav { DISPLAY: none } .script { DISPLAY: none } ------=_NextPart_000_0084_01C7B8B5.99126760 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://www.atsdr.cdc.gov/css/atsdr_print.css BODY { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: #ffffff; = PADDING-BOTTOM: 0px; MARGIN: 0px; FONT: 0.7em Arial, Helvetica, = sans-serif; COLOR: #000; PADDING-TOP: 0px } #container { PADDING-RIGHT: 20px; PADDING-LEFT: 20px; PADDING-BOTTOM: 20px; MARGIN: = 10px 20px; WIDTH: auto; BORDER-TOP-STYLE: none; PADDING-TOP: 20px; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; BORDER-BOTTOM-STYLE: = none } #banner { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; MARGIN-BOTTOM: 14px; = PADDING-BOTTOM: 0px; PADDING-TOP: 0px } #sidebar-a { DISPLAY: none } #sidebar-b { DISPLAY: none } #footer { DISPLAY: none } #skipnav { DISPLAY: none } HR { DISPLAY: none } P { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } SPAN { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } UL { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } LI { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } A { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } P { LINE-HEIGHT: 1.8em } UL { LINE-HEIGHT: 1.6em } OL { LINE-HEIGHT: 1.6em } DL { LINE-HEIGHT: 1.6em } A.tE { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000; TEXT-DECORATION: = underline } #headerwrap { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; WIDTH: auto; BORDER-TOP-STYLE: none; PADDING-TOP: 0px; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; BACKGROUND-COLOR: = #fff; BORDER-BOTTOM-STYLE: none } #globalnav { DISPLAY: none } #header { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND-IMAGE: = url(http://www.cdc.gov/i/bgHdr.gif); PADDING-BOTTOM: 0px; MARGIN: 0px; = PADDING-TOP: 0px } #header .logo { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND-IMAGE: = url(http://www.cdc.gov/i/bgHdr.gif); PADDING-BOTTOM: 0px; MARGIN: 0px; = PADDING-TOP: 0px } .logo IMG { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 8px; MARGIN: = 0px; PADDING-TOP: 8px } #header .spanish { DISPLAY: none } #header .form { DISPLAY: none } #topnav { DISPLAY: none } #leftnav { DISPLAY: none } #ftrwrap { DISPLAY: none } #contentnav { DISPLAY: none } #spotlight { BORDER-RIGHT: #000 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: #000 1px = solid; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; FONT: 1em = Arial, Helvetica, sans-serif; BORDER-LEFT: #000 1px solid; WIDTH: 365px; = PADDING-TOP: 0px; BORDER-BOTTOM: #000 1px solid; BACKGROUND-COLOR: #fff } #spotlight H2 { PADDING-RIGHT: 0px; PADDING-LEFT: 10px; FONT-WEIGHT: bold; FONT-SIZE: = 120%; PADDING-BOTTOM: 2px; MARGIN: 0px; COLOR: #fff; PADDING-TOP: 3px; = BACKGROUND-COLOR: #000 } UL#newslist { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 95%; PADDING-BOTTOM: = 0px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none } #newslist LI { PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 0px; MARGIN: = 0px; PADDING-TOP: 10px } #newslist LI.first { PADDING-TOP: 13px } #newslist LI.last { PADDING-BOTTOM: 10px } #newslist IMG.thumb { BORDER-RIGHT: #000 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: #000 1px = solid; PADDING-LEFT: 0px; FLOAT: left; PADDING-BOTTOM: 0px; BORDER-LEFT: = #000 1px solid; MARGIN-RIGHT: 10px; PADDING-TOP: 0px; BORDER-BOTTOM: = #000 1px solid } #newslist A { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000; TEXT-DECORATION: = underline } #newslist P { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } SPAN { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } #newslist A.tE { FONT-WEIGHT: bold } #rightnav { DISPLAY: none } #toolsbox { DISPLAY: none } #content { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; WIDTH: auto; BORDER-TOP-STYLE: none; PADDING-TOP: 0px; = BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: none; BACKGROUND-COLOR: = #fff; BORDER-BOTTOM-STYLE: none } #content P { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } SPAN { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } UL { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } LI { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } A { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000 } #content A.tE { FONT-WEIGHT: bold } #content .banner IMG { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; MARGIN-BOTTOM: 10px; = PADDING-BOTTOM: 0px; PADDING-TOP: 0px; BORDER-BOTTOM: #000 2px solid } #contentlist { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; PADDING-BOTTOM: = 0px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none } #contentlist LI { FONT-SIZE: 100%; MARGIN-BOTTOM: 0.5em; PADDING-TOP: 5px } #contentlist LI.last { PADDING-BOTTOM: 5px } #contentlist LI A { FONT-WEIGHT: normal; FONT-SIZE: 100%; COLOR: #000 } #contentlist LI A.tE { FONT-WEIGHT: bold; FONT-SIZE: 100%; COLOR: #000 } #contentlist UL.list A { FONT-WEIGHT: normal; FONT-SIZE: 100%; COLOR: #000; TEXT-DECORATION: = underline } .spacer2 { BACKGROUND-POSITION: left top; BACKGROUND-IMAGE: url(../images/s.gif); = VERTICAL-ALIGN: top; WIDTH: 1px; BACKGROUND-REPEAT: no-repeat; HEIGHT: = 5px; TEXT-ALIGN: center } #cnt_wrap { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; FONT: 1em Arial, Helvetica, sans-serif; WIDTH: auto; = BORDER-TOP-STYLE: none; PADDING-TOP: 0px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; BACKGROUND-COLOR: #fff; BORDER-BOTTOM-STYLE: = none } #cnt_wrap H2 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: = 120%; PADDING-BOTTOM: 2px; MARGIN: 0px; COLOR: #000; PADDING-TOP: 3px; = BACKGROUND-COLOR: #fff } #cnt_wrap H3 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: = 115%; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: #000; PADDING-TOP: 0px; = BACKGROUND-COLOR: #fff } #cnt_wrap H4 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: = 110%; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: #000; PADDING-TOP: 0px; = BACKGROUND-COLOR: #fff } #cnt_wrap H5 { FONT-WEIGHT: bold; FONT-SIZE: 100%; MARGIN-BOTTOM: -10px; COLOR: #000; = PADDING-TOP: 0px; BACKGROUND-COLOR: #fff } #cnt_wrap .pdf_dwnld { DISPLAY: none } #cnt_wrap .usmap { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; PADDING-TOP: 10px; TEXT-ALIGN: left } #cnt_wrap .usmap A { DISPLAY: block; FONT-SIZE: 95%; MARGIN-BOTTOM: 5px; TEXT-ALIGN: right; = TEXT-DECORATION: underline } #cnt_wrap UL { LIST-STYLE-TYPE: square } .top { DISPLAY: none } .pdf_dwnld { DISPLAY: none } #cnt_wrap .legendbox { BORDER-RIGHT: #e5e5e5 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: = #e5e5e5 1px solid; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; = BORDER-LEFT: #e5e5e5 1px solid; WIDTH: 365px; PADDING-TOP: 0px; = BORDER-BOTTOM: #e5e5e5 1px solid; BACKGROUND-COLOR: #fff } #cnt_wrap UL#lgndlist { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 95%; PADDING-BOTTOM: = 0px; MARGIN: 0.6em; PADDING-TOP: 0px; LIST-STYLE-TYPE: none } #lgndlist LI { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; = PADDING-BOTTOM: 6px; MARGIN: 0px; PADDING-TOP: 0px } #lgndlist LI.last { PADDING-BOTTOM: 0px } #lgndlist IMG.lgnd { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FLOAT: left; MARGIN-BOTTOM: 6px; = PADDING-BOTTOM: 0px; MARGIN-RIGHT: 4px; PADDING-TOP: 0px } #cnttopnav { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; FONT: 1em Arial, Helvetica, sans-serif; WIDTH: 365px; = BORDER-TOP-STYLE: none; PADDING-TOP: 0px; BORDER-RIGHT-STYLE: none; = BORDER-LEFT-STYLE: none; BACKGROUND-COLOR: #fff; BORDER-BOTTOM-STYLE: = none } #cnttopnav H2 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: = 120%; PADDING-BOTTOM: 2px; MARGIN: 0px; COLOR: #000; PADDING-TOP: 3px; = BACKGROUND-COLOR: #fff } #cnttopnav H3 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: = 115%; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: #000; PADDING-TOP: 0px; = BACKGROUND-COLOR: #fff } #cnttopnav H4 { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: = 110%; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: #000; PADDING-TOP: 0px; = BACKGROUND-COLOR: #fff } #cnttopnavlist { PADDING-LEFT: 0px; FONT-SIZE: 100%; LIST-STYLE-IMAGE: = url(../images/blt.gif); MARGIN: 0.5em 0.5em 0px 25px; LIST-STYLE-TYPE: = square } #cnttopnavlist LI { PADDING-LEFT: 0px; FONT-SIZE: 100%; MARGIN-BOTTOM: 0.3em; MARGIN-LEFT: = 0px } #cnttopnavlist A { FONT: 100% Arial, Helvetica, sans-serif; COLOR: #000; TEXT-DECORATION: = underline } #cnttopnav IMG.thumb { BORDER-RIGHT: #999999 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: = #999999 1px solid; MARGIN-TOP: 6px; PADDING-LEFT: 0px; FLOAT: right; = PADDING-BOTTOM: 0px; MARGIN-LEFT: 4px; BORDER-LEFT: #999999 1px solid; = PADDING-TOP: 0px; BORDER-BOTTOM: #999999 1px solid } ------=_NextPart_000_0084_01C7B8B5.99126760 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://www.atsdr.cdc.gov/JScript/s_code.js /************************ ADDITIONAL FEATURES ************************ Plugins */ /************************** CONFIG SECTION **************************/ /* You may add or alter any code config here. */ /* Specify the life time of the cookie in seconds, or */ /* set to "Session" to turn off persistent cookies. */ var s_cookieLifetime=3D"Session" /* Variables (s_pageName, s_prop1, etc.) not prefixed with "s_" will not = be used. */ var s_disableLegacyVars=3Dtrue /* E-commerce Config */ var s_eVarCFG=3D"" /* Link Tracking Config */ var s_trackDownloadLinks=3Dtrue var s_trackExternalLinks=3Dtrue var s_trackInlineStats=3Dtrue var = s_linkDownloadFileTypes=3D"exe,zip,wav,mp3,mov,mpg,avi,doc,pdf,xls,rm,wmv= " var = s_linkInternalFilters=3D"javascript:,cdc,file:///,outbind,//www/,mid://,c= dc" var s_linkLeaveQueryString=3Dfalse var s_linkTrackVars=3D"None" var s_linkTrackEvents=3D"None" /* Plugin Config */ var s_usePlugins=3Dtrue function s_doPlugins() { var = ds=3D["bam.gov","cdc.gov","mid://","http://198.246.96.2","outbind:"]; var dlh=3Ds_wd.location.href.toLowerCase(); var cond=3Dfalse; for(var i=3D0;i0){var vs=3Ds_wd.s_vp_favs,p=3Ds_gg('pageName'),fn, f,en,el,t,oc,och;for(fn=3D0;fn=3D0)||(oc.indexOf( 'form.')>=3D0))&&oc.indexOf("submit(")>=3D0)el.onclick=3Ds_vp_fasu;else el.onclick=3Ds_vp_fac}else{el.s_vp_faoch=3Del.onchange;if(((f.name&& och.indexOf(f.name)>=3D0)||(och.indexOf('form.')>=3D0))&&och.indexOf( "submit(")>=3D0)el.onchange=3Ds_vp_fasu;else el.onchange=3Ds_vp_fac }}} }f.s_vp_faos=3Df.onsubmit;f.onsubmit=3Ds_vp_fasu}s_wd.s_vp_faul=3D s_wd.onunload;s_wd.onunload=3Ds_vp_fa}return r}function s_vp_fa(e){ var vs=3Ds_wd.s_vp_favs;if(vs&&s_wd[vs]){s_lnk=3Dnew Object s_linkType=3Ds_wd.s_vp_falt;s_linkName=3Ds_wd.s_vp_faln;s_gs('') s_lnk=3D''}if(s_wd.s_ful)return s_wd.s_ful(e);return true} function s_vp_fasu(e){var vs=3Ds_wd.s_vp_favs;if(vs)s_wd[vs]=3D'';if( this.s_vp_faos)return this.s_vp_faos(e);if(this.s_vp_faoc) return this.s_vp_faoc(e);if(this.s_vp_faoch) return this.s_vp_faoch(e);return true}function s_vp_fac(e){var b=3D "s_gs(",vs=3Ds_wd.s_vp_favs,f=3Dthis.form,p=3Ds_gg('pageName');if(vs) s_wd[vs]=3D(f.name?f.name:(p?p:''))+':'+(this.name?this.name:'') if(this.s_vp_faoc)return this.s_vp_faoc(e);if(this.s_vp_faoch) return this.s_vp_faoch(e);return true} /* * Plugin Utilities v2.0 (Required For All Plugins) */ function s_vpr(vs,v){if(s_wd[vs])s_wd[vs]=3Ds_wd[vs];else s_wd[vs]=3D'' if(vs.substring(0,2) =3D=3D = 's_')vs=3Dvs.substring(2);s_wd['s_vpv_'+vs]=3Dv s_wd['s_vpm_'+vs]=3D1}function s_dt(tz,t){var d=3Dnew = Date;if(t)d.setTime( t);d=3Dnew Date(d.getTime()+(d.getTimezoneOffset()*60*1000)) return new Date(Math.floor(d.getTime()+(tz*60*60*1000)))} function s_vh_gt(k,v){var = vh=3D'|'+s_c_r('s_vh_'+k),vi=3Dvh.indexOf('|'+v +'=3D'),ti=3Dvi<0?vi:vi+2+v.length,pi=3Dvh.indexOf('|',ti),t=3Dti<0?'': vh.substring(ti,pi<0?vh.length:pi);return t}function s_vh_gl(k){var vh=3Ds_c_r('s_vh_'+k),e=3Dvh?vh.indexOf('=3D'):0;return = vh?(vh.substring(0, e?e:vh.length)):''}function s_vh_s(k,v){if(k&&v){var e=3Dnew Date,st=3D e.getTime(),y=3De.getYear(),c=3D's_vh_'+k,vh=3D'|'+s_c_r(c)+'|',t=3Ds_vh_= gt(k, v);e.setYear((y<1900?y+1900:y)+5);if(t)vh=3Ds_rep(vh,'|'+v+'=3D'+t+'|','|= ' );if(vh.substring(0,1)=3D=3D'|')vh=3Dvh.substring(1);if(vh.substring( vh.length-1,vh.length)=3D=3D'|')vh=3Dvh.substring(0,vh.length-1);vh=3Dv +'=3D[PCC]'+(vh?'|'+vh:'');s_c_w(c,vh,e);if(s_vh_gt(k,v)!=3D'[PCC]') return 0;vh=3Ds_rep(vh,'[PCC]',st);s_c_w(c,vh,e)}return 1} /************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/ var = s_un,s_ios=3D0,s_q=3D'',s_code=3D'',code=3D'',s_bcr=3D0,s_lnk=3D'',s_eo=3D= '', s_vb,s_pl,s_tfs=3D0,s_etfs=3D0,s_wd=3Dwindow,s_d=3Ds_wd.document,s_ssl=3D= ( s_wd.location.protocol.toLowerCase().indexOf('https')>=3D0),s_n=3D navigator,s_u=3Ds_n.userAgent,s_apn=3Ds_n.appName,s_v=3Ds_n.appVersion, s_apv,s_i,s_ie=3Ds_v.indexOf('MSIE '),s_ns6=3Ds_u.indexOf('Netscape6/') if(s_v.indexOf('Opera')>=3D0||s_u.indexOf('Opera')>=3D0)s_apn=3D'Opera';v= ar s_isie=3D(s_apn=3D=3D'Microsoft Internet = Explorer'),s_isns=3D(s_apn=3D=3D 'Netscape'),s_isopera=3D(s_apn=3D=3D'Opera'),s_ismac=3D(s_u.indexOf('Mac'= )>=3D0) if(s_ie>0){s_apv=3DparseInt(s_i=3Ds_v.substring(s_ie+5));if(s_apv>3)s_apv= =3D parseFloat(s_i)}else if(s_ns6>0)s_apv=3DparseFloat(s_u.substring(s_ns6 +10));else s_apv=3DparseFloat(s_v);function s_fl(s,l){return (s+'' ).substring(0,l)}function s_co(o){if(!o)return o;var n=3Dnew Object for(x in o)n[x]=3Do[x];return n}function s_num(x){var = s=3Dx.toString(),g=3D '0123456789',p,d;for(p=3D0;p0?n.length:1;while(s&&i>=3D0){s=3Ds.substring(0= ,i) +n+s.substring(i+o.length);i=3Ds.indexOf(o,i+l)}return s}function s_ape( s){return s?s_rep(escape(''+s),'+','%2B'):s}function s_epa(s){ return s?unescape(s_rep(''+s,'+',' ')):s}function s_pt(s,d,f,a){var t=3D s,x=3D0,y,r;while(t){y=3Dt.indexOf(d);y=3Dy<0?t.length:y;t=3Dt.substring(= 0,y) r=3Df(t,a);if(r)return = r;x+=3Dy+d.length;t=3Ds.substring(x,s.length);t=3Dx< s.length?t:''}return ''}function = s_isf(t,a){if(t.substring(0,2)=3D=3D's_') t=3Dt.substring(2);return (t!=3D''&&t=3D=3Da)}function = s_fsf(t,a){if(s_pt(a, ',',s_isf,t))s_fsg+=3D(s_fsg!=3D''?',':'')+t;return 0}var s_fsg function s_fs(s,f){s_fsg=3D'';s_pt(s,',',s_fsf,f);return s_fsg}var s_c_d=3D'';function s_c_gdf(t,a){if(!s_num(t))return 1;return 0} function s_c_gd(){var d=3Ds_wd.location.hostname,n=3Ds_gg( 'cookieDomainPeriods'),p;if(d&&!s_c_d){n=3Dn?parseInt(n):2;n=3Dn>2?n:2;p=3D= d.lastIndexOf('.');while(p>=3D0&&n>1){p=3Dd.lastIndexOf('.',p-1);n--} s_c_d=3Dp>0&&s_pt(d,'.',s_c_gdf,0)?d.substring(p):''}return s_c_d} function s_c_r(k){k=3Ds_ape(k);var c=3D' '+s_d.cookie,s=3Dc.indexOf(' = '+k +'=3D'),e=3Ds<0?s:c.indexOf(';',s),v=3Ds<0?'':s_epa(c.substring(s+2 +k.length,e<0?c.length:e));return v}function s_c_w(k,v,e){var d=3D s_c_gd(),l=3Ds_gg('cookieLifetime');v=3D''+v;l=3Dl?(''+l).toUpperCase():'= ' if(e&&l!=3D'SESSION'&&l!=3D'NONE'){l=3DparseInt(l);if(l){e=3Dnew Date e.setTime(e.getTime()+(parseInt(l)*1000))}}if(k&&l!=3D'NONE'){ s_d.cookie=3Dk+'=3D'+s_ape(v)+'; path=3D/;'+(e&&l!=3D'SESSION'?' = expires=3D' +e.toGMTString()+';':'')+(d?' domain=3D'+d+';':'');return = s_c_r(k)=3D=3Dv} return 0}function s_cet(f,a,et,oe,fb){var r,d=3D0 /*@cc_on@if(@_jscript_version>=3D5){try{return f(a)}catch(e){return = et(e)}d=3D1}@end@*/ if(!d){if(s_ismac&&s_u.indexOf('MSIE 4')>=3D0)return fb(a);else{ s_wd.s_oe=3Ds_wd.onerror;s_wd.onerror=3Doe;r=3Df(a);s_wd.onerror=3Ds_wd.s= _oe return r}}}function s_gtfset(e){return s_tfs}function s_gtfsoe(e){ s_wd.onerror=3Ds_wd.s_oe;s_etfs=3D1;var = code=3Ds_gs(s_un);if(code)s_d.write( code);s_etfs=3D0;return true}function s_gtfsfb(a){return s_wd} function s_gtfsf(w){var p=3Dw.parent,l=3Dw.location;s_tfs=3Dw;if(p&& p.location!=3Dl&&p.location.host=3D=3Dl.host){s_tfs=3Dp;return = s_gtfsf(s_tfs)} return s_tfs}function = s_gtfs(){if(!s_tfs){s_tfs=3Ds_wd;if(!s_etfs)s_tfs=3D s_cet(s_gtfsf,s_tfs,s_gtfset,s_gtfsoe,s_gtfsfb)}return s_tfs} function s_ca(un){un=3Dun.toLowerCase();var = ci=3Dun.indexOf(','),fun=3Dci<0? un:un.substring(0,ci),imn=3D's_i_'+fun;if(s_d.images&&s_apv>=3D3&& !s_isopera&&(s_ns6<0||s_apv>=3D6.1)){s_ios=3D1;if(!s_d.images[imn]&&( !s_isns||(s_apv<4||s_apv>=3D5))){s_d.write('');if(!s_d.images[imn])s_ios=3D0}}} function s_it(un){s_ca(un)}function s_mr(un,sess,q,ta){un=3D un.toLowerCase();var = ci=3Dun.indexOf(','),fun=3Dci<0?un:un.substring(0,ci ),unc=3Ds_rep(fun,'_','-'),imn=3D's_i_'+fun,im,b,e,rs=3D'http'+(s_ssl?'s'= :'' )+'://mtrics.cdc.gov/b/ss/'+un+'/1/G.5-Pd-S/' +sess+'?[AQB]&ndh=3D1'+(q?q:'')+(s_q?s_q:'')+'&[AQE]';if(s_ios){im=3Ds_wd= [ imn]?s_wd[imn]:s_d.images[imn];if(!im)im=3Ds_wd[imn]=3Dnew = Image;im.src=3Drs if(rs.indexOf('&pe=3D')>=3D0&&(!ta||ta=3D=3D'_self'||ta=3D=3D'_top'||(s_w= d.name&& ta=3D=3Ds_wd.name))){b=3De=3Dnew = Date;while(e.getTime()-b.getTime()<500)e=3D new Date}return ''}return ''}function s_gg(v){var = g=3D's_'+v return s_wd[g]||s_wd.s_disableLegacyVars?s_wd[g]:s_wd[v]}var s_qav=3D'' function s_havf(t,a){var b=3Dt.substring(0,4),s=3Dt.substring(4),n=3D parseInt(s),k=3D's_g_'+t,m=3D's_vpm_'+t,q=3Dt,v=3Ds_gg('linkTrackVars'),e= =3D s_gg('linkTrackEvents');if(!s_wd['s_'+t])s_wd['s_'+t]=3D'';s_wd[k]=3Ds_wd= [ m]?s_wd['s_vpv_'+t]:s_gg(t);if(s_lnk||s_eo){v=3Dv?v+',pageName,charSet,' +'cookieDomainPeriods,cookieLifetime,eVarCFG,purchaseID':'';if(v&& !s_pt(v,',',s_isf,t))s_wd[k]=3D'';if(t=3D=3D'events'&&e)s_wd[k]=3Ds_fs(s_= wd[k ],e)}s_wd[m]=3D0;if(t=3D=3D'charSet')q=3D'ce';else = if(t=3D=3D'cookieDomainPeriods' )q=3D'cdp';else if(t=3D=3D'cookieLifetime')q=3D'cl';else = if(t=3D=3D'channel')q=3D 'ch';else if(t=3D=3D'campaign')q=3D'v0';else = if(s_num(s)){if(b=3D=3D'prop')q=3D'c' +n;else if(b=3D=3D'eVar')q=3D'v'+n;else = if(b=3D=3D'hier')q=3D'h'+n}if(s_wd[k]&&t!=3D 'linkName'&&t!=3D'linkType')s_qav+=3D'&'+q+'=3D'+s_ape(s_wd[k]);return = ''} function s_hav(){var n,av=3D'charSet,cookieDomainPeriods,cookieLifetime' +',pageName,channel,server,pageType,campaign,state,zip,events,product' +'s,purchaseID,eVarCFG,linkName,linkType';for(n=3D1;n<26;n++)av+=3D',prop= ' +n+',eVar'+n+',hier'+n;s_qav=3D'';s_pt(av,',',s_havf,0);return s_qav} function = s_lnf(t,h){t=3Dt?t.toLowerCase():'';h=3Dh?h.toLowerCase():'';var te=3Dt.indexOf('=3D');if(t&&te>0&&h.indexOf(t.substring(te+1))>=3D0) return t.substring(0,te);return ''}function s_ln(h){if(s_gg( 'linkNames'))return s_pt(s_gg('linkNames'),',',s_lnf,h);return ''} function = s_ltdf(t,h){t=3Dt?t.toLowerCase():'';h=3Dh?h.toLowerCase():'';var qi=3Dh.indexOf('?');h=3Dqi>=3D0?h.substring(0,qi):h;if(t&&h.substring( h.length-(t.length+1))=3D=3D'.'+t)return 1;return 0}function = s_ltef(t,h){ t=3Dt?t.toLowerCase():'';h=3Dh?h.toLowerCase():'';if(t&&h.indexOf(t)>=3D0= ) return 1;return 0}function s_lt(h){var lft=3Ds_gg( 'linkDownloadFileTypes'),lef=3Ds_gg('linkExternalFilters'),lif=3Ds_gg( 'linkInternalFilters')?s_gg('linkInternalFilters'): s_wd.location.hostname;h=3Dh.toLowerCase();if(s_gg('trackDownloadLinks' )&&lft&&s_pt(lft,',',s_ltdf,h))return 'd';if(s_gg('trackExternalLinks' )&&(lef||lif)&&(!lef||s_pt(lef,',',s_ltef,h))&&(!lif||!s_pt(lif,',', s_ltef,h)))return 'e';return ''}function s_lc(e){s_lnk=3Ds_co(this) s_gs('');s_lnk=3D'';if(this.s_oc)return this.s_oc(e);return true} function s_ls(){var l,ln,oc;for(ln=3D0;ln=3D0?','+t.substring(0,e) +',':'';return u&&u.indexOf(','+un+',')>=3D0?s_epa(t.substring(e+1)):''} function s_rq(un){var = c=3Dun.indexOf(','),v=3Ds_c_r('s_sq'),q=3D'';if(c<0) return s_pt(v,'&',s_rqf,un);return s_pt(un,',',s_rq,0)}var s_sqq,s_squ function s_sqp(t,a){var = e=3Dt.indexOf('=3D'),q=3De<0?'':s_epa(t.substring(e +1));s_sqq[q]=3D'';if(e>=3D0)s_pt(t.substring(0,e),',',s_sqs,q);return = 0} function s_sqs(un,q){s_squ[un]=3Dq;return 0}function s_sq(un,q){s_sqq=3D new Object;s_squ=3Dnew Object;s_sqq[q]=3D'';var = k=3D's_sq',v=3Ds_c_r(k),x,c=3D0 s_pt(v,'&',s_sqp,0);s_pt(un,',',s_sqs,q);v=3D'';for(x in s_squ)s_sqq[ s_squ[x]]+=3D(s_sqq[s_squ[x]]?',':'')+x;for(x in s_sqq)if(x&&s_sqq[x]&&( x=3D=3Dq||c<2)){v+=3D(v?'&':'')+s_sqq[x]+'=3D'+s_ape(x);c++}return = s_c_w(k,v,0 )}function s_wdl(e){s_wd.s_wd_l=3D1;var = r=3Dtrue;if(s_wd.s_ol)r=3Ds_wd.s_ol( e);if(s_wd.s_ls)s_wd.s_ls();return r}function s_wds(un){un=3D un.toLowerCase();s_wd.s_wd_l=3D1;if(s_apv>3&&(!s_isie||!s_ismac||s_apv>=3D= 5)){s_wd.s_wd_l=3D0;if(!s_wd.s_unl)s_wd.s_unl=3Dnew Array;s_wd.s_unl[ s_wd.s_unl.length]=3Dun;if(s_d.body&&s_d.body.attachEvent){if( !s_wd.s_bcr&&s_d.body.attachEvent('onclick',s_bc))s_wd.s_bcr=3D1} else if(s_d.body&&s_d.body.addEventListener){if(!s_wd.s_bcr&& s_d.body.addEventListener('click',s_bc,false))s_wd.s_bcr=3D1}else{var ol=3Ds_wd.onload?s_wd.onload.toString():'';if(ol.indexOf("s_wdl(")<0){ s_wd.s_ol=3Ds_wd.onload;s_wd.onload=3Ds_wdl}}}}function s_iepf(i,a){if( i.substring(0,1)!=3D'{')i=3D'{'+i+'}';if(s_d.body.isComponentInstalled(i,= 'ComponentID')){var n=3Ds_pl.length;s_pl[n]=3Dnew = Object;s_pl[n].name=3Di +':'+s_d.body.getComponentVersion(i,'ComponentID')}return 0} function s_vs(un,x){var s=3Ds_gg('visitorSampling'),g=3Ds_gg( 'visitorSamplingGroup'),k=3D's_vsn_'+un+(g?'_'+g:''),n=3Ds_c_r(k),e=3D new Date,y=3De.getYear();e.setYear(y+10+(y<1900?1900:0));if(s){s*=3D100 if(!n){if(!s_c_w(k,x,e))return 0;n=3Dx}if(n%10000>s)return 0}return 1} function s_gs(un){un=3Dun.toLowerCase() s_un=3Dun;var trk=3D1,tm=3Dnew Date,sed=3DMath&&Math.random?Math.floor( Math.random()*10000000000000):tm.getTime(),sess=3D's'+Math.floor( tm.getTime()/10800000)%10+sed,yr=3Dtm.getYear(),t,ta=3D'',q=3D'',qs=3D'';= yr=3D yr<1900?yr+1900:yr;t=3Dtm.getDate()+'/'+tm.getMonth()+'/'+yr+' ' +tm.getHours()+':'+tm.getMinutes()+':'+tm.getSeconds()+' '+tm.getDay() +' '+tm.getTimezoneOffset();if(!s_q){var = tfs=3Ds_gtfs(),tl=3Dtfs.location, r=3Dtfs.document.referrer,s=3D'',c=3D'',v=3D'',p=3D'',bw=3D'',bh=3D'',j=3D= '1.0',g=3D s_wd.location,k=3Ds_c_w('s_cc','true',0)?'Y':'N',hp=3D'',ct=3D'',iepl=3Ds= _gg( 'iePlugins'),pn=3D0,ps;if(s_apv>=3D4)s=3Dscreen.width+'x'+screen.height;i= f( s_isns||s_isopera){if(s_apv>=3D3){j=3D'1.1';v=3Ds_n.javaEnabled()?'Y':'N'= if(s_apv>=3D4){j=3D'1.2';c=3Dscreen.pixelDepth;bw=3Ds_wd.innerWidth;bh=3D= s_wd.innerHeight;if(s_apv>=3D4.06)j=3D'1.3'}}s_pl=3Ds_n.plugins}else if( s_isie){if(s_apv>=3D4){v=3Ds_n.javaEnabled()?'Y':'N';j=3D'1.2';c=3D screen.colorDepth;if(s_apv>=3D5){bw=3Ds_d.documentElement.offsetWidth;bh=3D= s_d.documentElement.offsetHeight;j=3D'1.3';if(!s_ismac&&s_d.body){ s_d.body.addBehavior("#default#homePage");hp=3Ds_d.body.isHomePage(tl)? "Y":"N";s_d.body.addBehavior("#default#clientCaps");ct=3D s_d.body.connectionType;if(iepl){s_pl=3Dnew Array;s_pt(iepl,',',s_iepf, '');}}}}else r=3D'';if(!s_pl&&iepl)s_pl=3Ds_n.plugins}if(s_pl)while(pn< s_pl.length&&pn<30){ps=3Ds_fl(s_pl[pn].name,100)+';';if(p.indexOf(ps)<0) p+=3Dps;pn++}s_q=3D(g?'&g=3D'+s_ape(s_fl(g,255)):'')+(r?'&r=3D'+s_ape(s_f= l(r, 255)):'')+(s?'&s=3D'+s_ape(s):'')+(c?'&c=3D'+s_ape(c):'')+(j?'&j=3D'+j:''= )+( v?'&v=3D'+v:'')+(k?'&k=3D'+k:'')+(bw?'&bw=3D'+bw:'')+(bh?'&bh=3D'+bh:'')+= (ct? '&ct=3D'+s_ape(ct):'')+(hp?'&hp=3D'+hp:'')+(s_vb?'&vb=3D'+s_vb:'')+(p?'&p= =3D' +s_ape(p):'')}if(s_gg('usePlugins'))s_wd.s_doPlugins();q+=3D(t?'&t=3D' +s_ape(t):'')+s_hav();if(s_lnk||s_eo){var o=3Ds_eo?s_eo:s_lnk;if(!o) return '';var = p=3Ds_wd.s_g_pageName,w=3D1,t=3Ds_ot(o),n=3Ds_oid(o),x=3Do.s_oidt, h,l,i,oc;if(s_eo&&o=3D=3Ds_eo){while(o&&!n&&t!=3D'BODY'){o=3Do.parentElem= ent? o.parentElement:o.parentNode;if(!o)return = '';t=3Ds_ot(o);n=3Ds_oid(o);x=3D o.s_oidt}oc=3Do.onclick?o.onclick.toString():'';if(oc.indexOf("s_gs(")>=3D= 0)return = ''}ta=3Do.target;h=3Do.href?o.href:'';i=3Dh.indexOf('?');h=3Ds_gg( 'linkLeaveQueryString')||i<0?h:h.substring(0,i);l=3Ds_gg('linkName')? s_gg('linkName'):s_ln(h);t=3Ds_gg('linkType')?s_gg('linkType' ).toLowerCase():s_lt(h);if(t&&(h||l))q+=3D'&pe=3Dlnk_'+(t=3D=3D'd'||t=3D=3D= 'e'? s_ape(t):'o')+(h?'&pev1=3D'+s_ape(h):'')+(l?'&pev2=3D'+s_ape(l):'');else trk=3D0;if(s_gg('trackInlineStats')){if(!p){p=3Ds_wd.location.href;w=3D0}= p=3D p?s_fl(p,255):'';t=3Ds_ot(o);i=3Do.sourceIndex;if(s_gg('objectID')){n=3D s_gg('objectID');x=3D1;i=3D1}if(p&&n&&t)qs=3D'&pid=3D'+s_ape(p)+(w?'&pidt= =3D'+w: '')+'&oid=3D'+s_ape(n)+(x?'&oidt=3D'+x:'')+'&ot=3D'+s_ape(t)+(i?'&oi=3D'+= i:'') }s_wd.s_linkName=3Ds_wd.s_linkType=3Ds_wd.s_objectID=3Ds_lnk=3Ds_eo=3D'';= if( !s_wd.s_disableLegacyVars)s_wd.linkName=3Ds_wd.linkType=3Ds_wd.objectID=3D= '' }if(!trk&&!qs)return '';var = code=3D'';if(un){if(trk&&s_vs(un,sed))code+=3D s_mr(un,sess,q+(qs?qs:s_rq(un)),ta);s_sq(un,trk?'':qs)}else if( s_wd.s_unl)for(var unn=3D0;unn